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ABSTRACT 
Colorectal cancer is one of the most common cancers worldwide. Population-based studies of care and 
outcomes are essential to monitor the uptake of evidence-based treatment guidelines and identify 
groups most at risk of receiving sub-optimal care or experiencing poor outcomes. With the development 
of locally-managed Clinical Cancer Registries (ClinCR) in public facilities in many Area Health Services 
(AHS) since 2006, ‘patterns of care’ studies which previously relied on the collection of clinical 
information through time- and resource-intensive surveys or medical record audits now have the 
potential to be conducted using routinely collected data. However there is little experience with the use 
of ClinCR data for research. The purpose of this report is to assess the quality, coverage and 
completeness of ClinCR data for use in colorectal cancer services research, and to assess the feasibility 
of developing surgical process and outcomes indicators that rely on ClinCR data items. 
The records of people with a newly diagnosed cancer of the colon, rectum or anus registered by the 
NSW Central Cancer Registry (CCR) since 2000 were linked to the following data sources by the Centre 
for Health Record Linkage (CHeReL): all six AHS ClinCR datasets including the NSW Oncology Group 
colorectal dataset extension (only collected in two AHS), NSW Admitted Patients Data Collection (APDC), 
NSW Emergency Department Data Collection (EDDC), and NSW Registry of Births, Deaths and Marriages 
(RBDM). Data from the AHS ClinCR datasets were harmonised and combined (12,968 records for 5,452 
persons), then merged onto the CCR cohort along with the APDC and RBDM. After data cleaning, the 
final cohort included 37,593 colorectal cancer cases diagnosed between July 2000 and December 2008. 
The proportion of the cohort with a ClinCR record (coverage) increased from 73% in 2007 to 85% in 2008 
for those having a procedure of interest in a public hospital. This proportion is over 94% for all AHS with 
a ClinCR in 2008. Demographic, diagnostic and treatment items in the ClinCR have high rates of 
completeness (mainly over 90%). Staging items have lower levels of completeness (77-84%), and quality 
of care items are largely only available for less than 60% of people. While discordance of ClinCR items 
duplicated in other datasets ranges from 4-22% for staging items, diagnostic items and admission-
related dates, most demographic items have high concordance and the internal consistency of ClinCR 
date items is also high for the majority of records (82% with no illogical dates). ClinCR or dataset 
extension items are required for the calculation of 12 of 21 surgical outcome and evidence-based care 
indicators that could feasibly be developed from the linked cohort dataset. 
The ClinCR and colorectal dataset extension provide a range of data on cancer staging, clinical treatment 
and care processes that add valuable information to other routinely collected data. While there are 
limitations in the coverage and quality of the ClinCR and extension data, including difficulty determining 
whether records have been created for all treatment events, without these datasets the development of 
population-based surgical indicators from routinely collected sources would be greatly limited. 
Recommendations resulting from this report include concentrating resources on items that are unique 
to the ClinCR, increasing coverage to private facilities, determining accuracy of the recording of 
treatment events, and increasing the collection of the ClinCR and dataset extension to all AHS where 
they are not currently in operation. Further assessment of the quality of ClinCR data for other tumour 
types for research purposes is also recommended. 
5 
 
EXECUTIVE SUMMARY 
BACKGROUND 
Colorectal cancer (CRC) is the second most common registered cancer in New South Wales and is one of 
the most common cancers worldwide. High-quality evidence exists for treatment approaches in CRC 
that improves patient outcomes, but these are not always implemented in routine clinical care to all 
patients.  
Population-based studies of treatment, care pathways and outcomes are essential to monitor the 
uptake of evidence-based guidelines and identify groups most at risk of receiving sub-optimal care or 
experiencing poor outcomes. However, the collection of clinical information through surveys or medical 
record audits for these ‘patterns of care’ studies can be time- and resource-intensive. With the 
development of Clinical Cancer Registries in public facilities in many Area Health Services from 2006, 
there is now potential to conduct patterns of care studies using routinely collected data.  
Clinical Cancer Registries (ClinCR) contain items about cancer diagnosis, staging, surgical procedures, 
adjuvant therapy, and referral and consultations with specialists that provide additional depth to data 
collected by the Central Cancer Registry (CCR), Admitted Patients Data Collection (APDC) and Emergency 
Department Data Collection (EDDC). Linkage of these datasets and feedback of patterns of treatment 
and outcomes that are identified may stimulate improvements in cancer service delivery. 
The ClinCR is a relatively recent development and there is little experience with the use of these data for 
research. The purpose of this report is therefore to assess the quality, coverage and completeness of 
ClinCR data for use in colorectal cancer services research, and to assess the feasibility of developing 
surgical process and outcomes indicators that rely on ClinCR data items.  
AIMS 
1. To quantify the coverage of the Clinical Cancer Registry for people diagnosed with a new colorectal 
cancer in NSW in 2007 and 2008 
2. To quantify the proportion of missing data for each item in the Clinical Cancer Registry Minimum 
Data Set and Colorectal Cancer Data Set extension 
3. To investigate concordance between Clinical Cancer Registry and other administrative datasets for 
items which are duplicated across datasets 
4. To investigate associations between Clinical Cancer Registry items and closely related items in other 
administrative datasets 
5. To investigate the internal consistency of items (particularly date items) within the Clinical Cancer 
Registry 
6. To investigate the feasibility of calculating surgical process and outcomes indicators that are 
dependent on Clinical Cancer Registry data 
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METHODS 
The study sample comprised all people registered by the NSW Central Cancer Registry (CCR) with a 
newly diagnosed cancer of the colon, rectum or anus between 1 January 2000 and 31 December 2010. 
The data used for analysis were obtained from linkage of the datasets listed below. Record linkage was 
conducted by the Centre for Health Record Linkage (CHeReL) using probabilistic matching of person 
identifiers provided by data custodians. Numbered keys generated to identify individuals across data 
sources were returned to custodians who released the data stripped of other identifying information. 
• NSW Clinical Cancer Registries (ClinCR): Data from all six locally-managed Area Health Service (AHS) 
datasets which were created in 2006/2007. Information is collected only in public facilities. Items 
include demographic and system details, diagnostic, staging, clinical, treatment and care items. 
• NSW Oncology Group dataset extension for colorectal cancer: Additional clinical data items that 
complement the core ClinCR dataset. These data are only collected in two AHS. 
• NSW CCR: Population-based registry for cancer diagnosed or treated in NSW residents. Items for the 
linked dataset included demographic items, tumour details, and treatment details. 
• NSW Admitted Patients Data Collection (APDC): Records for hospital separations (discharges, 
transfer, deaths) and demographic details from all NSW facilities. 
• NSW Emergency Department Data Collection: Information on emergency department presentation 
within 30 days of hospital separation for individuals within the study cohort. 
• NSW Registry of Births, Death and Marriages (RBDM): Information about date of death. 
Data from the individual ClinCR datasets were harmonised and combined. The collated ClinCR dataset 
was restricted to colorectal cancer records from 2007 and 2008 (12,968 records for 5,452 persons). 
APDC, RBDM and ClinCR records were merged onto the CCR cohort. CCR records were excluded if they 
were not the first cancer notification, were not unique first cancers, occurred before July 2000, or had 
inconsistent hospital or death dates indicative of an incorrect link. Data from the CCR were available to 
the end of 2008. Patients with an admission for a procedure of interest were flagged. The final CCR 
cohort included 37,593 colorectal cancer cases diagnosed between July 2000 and December 2008. 
Coverage of the cohort by the ClinCR, completeness of ClinCR and dataset extension items, concordance 
between duplicate items across datasets, and internal consistently of ClinCR date items were examined. 
RESULTS 
Aim 1: Coverage of patient cohort 
• 56% of colorectal cancer cases registered in the CCR in 2007 and 2008 have a ClinCR record. 
• 73% of people diagnosed in 2007 and 85% of people in 2008 who had a procedure of interest in a 
public hospital have a ClinCR record. This proportion is over 94% for all AHS with a ClinCR in 2008. 
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Aim 2: Completeness of ClinCR and extension data items (for all records in the collated ClinCR dataset) 
• Demographic and diagnostic items: data are available for over 95% of people for every non-optional 
item except postcode (64%), indigenous status (74%), and histopathological grade (85%). 
• Staging items: non-optional staging items have completeness rates of 77% to 84%. 
• Treatment items: treatment modality is specified in only 49% of records. All admission-related, 
radiotherapy and chemotherapy dates have completeness of 91% or more, except for date of 
chemotherapy end (87%). Specific treatment items range between 86% and 99% completeness. 
• Quality of care: data are available for <60% of people for all items except psychosocial referral (69%) 
• Colorectal extension items (two AHS only): most items range between 53% to 81% completeness, 
although completeness is lower for rectal cancer specific items. 
Aims 3 and 4: Concordance with other datasets for duplicate and closely related items 
• 15 ClinCR items are duplicated or are closely related to items in other datasets. 
• Mismatching values make up 3% or less of data for all duplicate demographic items except for one 
country of birth item (25%). Greater discordance exists between staging and diagnostic items and 
admission-related dates (4% to 22%), though the size of the date differences are generally not large. 
Aim 5: Internal consistency of ClinCR items 
• 18% of ClinCR records have one or more sets of illogical dates. 
• While more illogical dates arise between dates of treatment or care and date of diagnosis, there are 
greater median discrepancies between dates of treatment or care and date of death. 
Aim 6: Feasibility of developing surgical indicators 
• ClinCR or dataset extension items are required for the calculation of 12 of 21 surgical outcome and 
evidence-based care indicators that could feasibly be developed from the linked cohort dataset. 
CONCLUSIONS  
The ClinCR and dataset extension provide a range of data on cancer staging, clinical treatment and care 
processes that add valuable information to other routinely collected data sources. There is good 
coverage of public facilities, with increases from 2007 to 2008. Completeness is high for demographic 
and staging items, though these items are largely already collected in other datasets. Concordance with 
other datasets and internal consistency is also high for the majority of items and records, though some 
discrepancies require further exploration. While there is high completeness of treatment items, the 
ClinCR is limited by low rates of data for care items and difficulty determining whether records have 
been created for all treatment events. However, the development of surgical indicators would be greatly 
limited without many items from the ClinCR and dataset extension. Recommendations resulting from 
this report include concentrating resources on items that are unique to the ClinCR, increasing coverage 
to private facilities, determining accuracy of the recording of treatment events, and increasing the 
collection of the ClinCR and dataset extension to all AHS where they are not currently in operation.   
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BACKGROUND 
Colorectal cancer (CRC) is the second most common registered cancer in New South Wales (NSW) and is 
one of the most common cancers worldwide.1,2 There is high-quality evidence from randomised trials of 
specific treatment approaches that will improve patient outcomes, but these treatments must be 
implemented in routine clinical care to be of benefit to patients. In Australia and internationally, there is 
evidence that clinical care for colorectal cancer is highly variable and is often not in accordance with 
evidence-based clinical practice guidelines.3-6 Within New South Wales (NSW), previous research has 
identified that in 2000, only 74% of patients with Dukes C colon cancer, and only around half of those 
with high-risk rectal cancer, were offered appropriate adjuvant chemo-radiotherapy in accordance with 
national evidence-based clinical practice guidelines. Older people were consistently less likely to be 
treated according to guidelines.6  
Population-based studies of patients’ treatments, care pathways and outcomes are essential to monitor 
the uptake of evidence-based practice and can identify groups who are most likely to receive sub-
optimal care or experience poor outcomes. To date, such ‘patterns of care’ studies have relied on 
surveys of patients and/or clinicians and/or medical record audits to collect clinical information. These 
methods of data collection are resource-intensive and take a considerable length of time to assemble 
and follow a prospective cohort of people. With the development of the Area Health Service-based 
Clinical Cancer Registries, there is now potential to conduct patterns of care studies using routinely 
collected data. With linkage of this clinical information to other datasets, namely the Central Cancer 
Registry (CCR), Admitted Patients Data Collection (APDC) and Emergency Department Data Collection 
(EDDC) through the Centre for Health Record Linkage (CHeReL), it is theoretically possible to collate 
comprehensive information about patients' diagnosis, treatment and outcomes in order to stimulate 
improvements in cancer service delivery. However, the Clinical Cancer Registries are a relatively recent 
development and there is little experience with the use of these data for research purposes.  
Clinical Cancer Registries (ClinCR) were established in five Area Health Services (AHS) (Sydney South 
West, Sydney West, North Sydney and Central Coast, South Eastern Sydney and Illawarra and North 
Coast Area Health Services) in 2006, with a registry in Hunter New England AHS commencing in 2007. 
Clinical Cancer Registries contain information about patients diagnosed or treated for cancer in public 
facilities within the AHS. Data items comprise a Minimum Data Set (MDS) relevant to all tumour types 
and cancer-specific extensions that have been developed by NSW Oncology Groups.7 The Minimum Data 
Set includes items about cancer diagnosis, cancer stage, additional information about surgical 
procedures, adjuvant therapy, referrals and consultations with medical and radiation oncologists. A 
major strength of this dataset is the depth of clinical information that is collected.  
For Clinical Cancer Registry data to be a useful addition to Central Cancer Registry and Admitted Patients 
Data Collection records in population-based record linkage research studies, the data must be available 
in a timely manner for a large proportion of the cohort or a representative subset (coverage), must have 
low levels of missing data (completeness) and must be accurate.  
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The purpose of the analyses contained in this report is to assess the quality and completeness of Clinical 
Cancer Registry data for use in colorectal cancer services research, and specifically to assess the 
feasibility of developing surgical process and outcomes indicators that rely on Clinical Cancer Registry 
data items for the numerator, denominator or for risk adjustment. The report pertains only to colorectal 
cancer as it is part of a larger data linkage study to develop and test composite indicators of colorectal 
cancer care using population-based administrative datasets. Similar assessments should be undertaken 
for other cancer sites. 
 
AIMS 
1. To quantify the coverage of the Clinical Cancer Registry for people diagnosed with a new colorectal 
cancer in NSW in 2007 and 2008 
2. To quantify the proportion of missing data for each item in the Minimum Data Set and Colorectal 
Cancer Data Set extension 
3. To investigate concordance between Clinical Cancer Registry and other administrative datasets for 
items which are duplicated across datasets 
4. To investigate associations between Clinical Cancer Registry items and closely related items in other 
administrative datasets 
5. To investigate the internal consistency of items (particularly date items) within the Clinical Cancer 
Registry 
6. To investigate the feasibility of calculating surgical process and outcomes indicators that are 
dependent on Clinical Cancer Registry data 
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METHODS 
Study cohort 
The study sample comprised all people registered by the NSW Central Cancer Registry (CCR) with a 
newly diagnosed cancer of the colon, rectum or anus (ICD-10-AM codes C18- C21) between 1 January 
2000 and 31 December 2010. 
Clinical Cancer Registry (ClinCR) data 
Six AHS-based Clinical Cancer Registries  
Clinical cancer registries (ClinCR) were established in five Area Health Services (AHS) (North Coast, 
Northern Sydney Central Coast, South Eastern Sydney Illawarra, Sydney South West, and Sydney West 
AHS) in 2006, and in Hunter New England AHS in 2007. Clinical Cancer Registries were not established in 
Greater Southern AHS or Greater Western AHS. Each ClinCR is managed locally, with data collection, 
data entry, quality control and data governance the responsibility of the AHS. It should be noted that the 
ClinCR covers only patients treated within public facilities within the AHS. Patients treated in private 
facilities are not included. 
Data items contained in the ClinCR include: 
• Demographic details: sex, age, country of birth, postcode, indigenous status 
• System details: AMO registration number, facility code 
• Diagnostic and staging items: date of diagnosis, primary site of cancer, best basis for diagnosis, 
histopathological grade, morphology, degree of spread, TNM staging 
• Clinical details: performance status at diagnosis, date of death, cause of death 
• Treatment items: date of admission, date of discharge, procedure codes, date of radiotherapy 
start, date of radiotherapy end, radiotherapy type, dose and fractions, date of systemic therapy 
start, date of systemic therapy end, systemic protocol, number of cycles, date of referral to 
cancer specialist, date of consultation with specialist, date of decision to treat, date of clinical 
trial enrolment, date of MDT, date of referral to palliative care, psycho-social referral to (type) 
The NSW Oncology Group for colorectal cancer also identified a dataset extension to complement the 
core clinical cancer dataset. The colorectal dataset extension aims to include the following 12 items:  
• Presentation (screening/symptoms/emergency), method of surgery, level of rectal cancer, 
residual tumour status, radial resection margin, lymphovascular invasion, number of nodes 
examined, number of nodes involved, date of resection, mismatch repair deficiency (MMRD), 
site of recurrence, date of recurrence 
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Creation of collated ClinCR dataset 
Access to the clinical cancer registries was provided for all six AHS: Sydney South West AHS (SSW), North 
Coast AHS (NC), Northern Sydney Central Coast AHS (NSCC), South Eastern Sydney Illawarra AHS (SESI), 
Sydney West AHS (SW), and Hunter New England AHS (HNE). Extension item data were also available for 
two AHS. To protect their identity, areas have been labeled AHS A to AHS F for this report (in no 
particular order). 
Many data items were common across all ClinCRs, however some were unique to individual Area 
datasets and many were recorded in different ways. Data were harmonised to best resemble the 
current data dictionary and to enable stacking (combining) of the datasets. This process included 
standardising data item names, cleaning erroneous data, standardising default codes, transforming data 
recorded as text strings to standard codes, determining meaning of Area-specific coding not recorded in 
the minimum dataset dictionary and reassigning codes, standardising items where different coding 
systems had been used (e.g. systemic protocol). Records containing no data besides PPN were also 
deleted. 
The different area datasets originally recorded procedure codes in different formats. Procedure items 
were collapsed so that all procedures for an admission were recorded in one row (up to 27). Duplicate 
records providing no extra information to other records were deleted. Records were then stacked 
(combined) to create one ClinCR dataset.  
While data from some AHS registries were available for those diagnosed in and before 2006, greater 
levels of data were recorded in all registries after 2006. Information was also available for persons who 
had subsequent cancers of other sites in some datasets. For this analysis, the ClinCR dataset was 
restricted to records with a date of diagnosis in 2007 and 2008 for which primary cancer site was 
recorded as colon, rectum or anus. Table 1 shows the flow of records and persons in creating the 
collated ClinCR. 12,968 records for 5,452 persons were included in the final dataset.  
Table 1: Flow of records in collated ClinCR creation 
 CHeReL linked 
records (persons) 
Received records 
with data 
(persons) 
Records after 
procedure collapse 
(persons) 
Records after 
deleting duplicates 
(persons) 
Restricted 
dataset records 
(persons)* 
AHS A 1,672 (585) 1,566 (503) 1,561 (503) 1,561 (503) 1,517 (487) 
AHS B 2,451 (953) 2,554 (953) 2,554 (953) 2,553 (953) 1,629 (586) 
AHS C 5,734 (2,390) 5,823 (2,183) 5,765 (2,183) 5,752 (2,183) 2,625 (1,002) 
AHS D 4,011 (2,082) 4,011 (2,082) 4,011 (2,082) 4,011 (2,082) 2,367 (1,265) 
AHS E 5,250 (4,012) 9,873 (4,011) 6,514 (4,011) 6,513 (4,011) 2,245 (1,462) 
AHS F 3,999 (1,416) 14,246 (1,416) 4,291 (1,416) 4,275 (1,416) 2,585 (873) 
Total 23,118 (10,986) 38,073 (10,723) 24,696 (10,723) 24,665 (10,723) 12,968 (5,452) 
* Restricted to colorectal cancer diagnosis in 2007 and 2008 
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Other data sets and data items available in colorectal linked dataset 
NSW Central Cancer Register (CCR) 
The NSW CCR was established in 1971 as a population-based registry for all cases of cancer diagnosed or 
treated in residents of NSW. Notification of cancer to the Registry is mandatory under the NSW Public 
Health Act 1991. The data items contained in this data collection that will were included in the linked 
dataset for the project include: 
• Demographic details (year of birth, age at diagnosis, sex, country of birth, indigenous status, 
postcode of residence, area health service (AHS) of residence, date of death, cause of death) 
• Tumour details (date of diagnosis, primary site, basis of diagnosis, morphology, degree of 
spread) 
• Treatment details (episode type, episode date, date of admission, date of separation, hospital 
code, AHS of hospital, hospital sector (public/private), principal procedure). 
 
NSW Admitted Patients Data Collection (APDC) 
The Admitted Patient Data Collection (APDC) is a population-based data collection that includes records 
for all hospital separations (discharges, transfers and deaths) from all NSW public and private hospitals 
and day procedure centres. Data items from this collection that were included in the linked dataset for 
the project include: 
• Demographic details (eg age, sex, country of birth, indigenous status, language spoken at home, 
marital status, postcode of residence) 
• Separation details (date of admission, date of separation, source of referral, discharge status 
and diagnosis and procedure codes using ICD-10-AM coding, including coding of significant 
comorbidities and complications). 
Validation studies have found approximately 95% agreement between principal diagnoses recorded in 
hospital inpatient statistics and corresponding clinical records.8 Data on procedures (which have 
financial implications for an organisation) are accurately recorded in almost all cases.8 ICD diagnosis 
codes were used to calculate a Charlson co-morbidity index.9 
 
NSW Emergency Department Data Collection 
Data in this dataset are derived from the Emergency Department Information System. Although the 
NSW Department of Health has highlighted that, over the longer term, lost linkages will occur when 
using this dataset (estimated at approximately 10% per year when hospital code and medical record 
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number are used for linkage), linkage of events that are close in time (within a few weeks) is considered 
to be reliable.10 For this project, linkage was restricted to a period of 30 days from hospital separation 
for individuals within the study cohort, so that rates emergency department presentation within 30 days 
can be assessed. Information is available from 1 Jan 2005. 
 
NSW Registry of Births, Deaths and Marriages (RBDM) 
Information about date of death was obtained from this source. 
 
Record linkage 
Record linkage was conducted by the Centre for Health Record Linkage (CHeReL) using probabilistic 
matching. Probabilistic matching conducted by the CHeReL involves data custodians providing person 
identifiers without any health information to the CHeReL. The CHeReL matches these identifiers across 
data sources, and generates a system of numbered keys to identify individuals. After providing data 
custodians with these keys, the custodians can release health information to researchers, identified only 
by the numbered keys and stripped of all other identifying information. At no time do researchers have 
access to identifying information, nor does the CHeReL have access to health information. This approach 
to preserving privacy and data governance has been strongly supported by organisations that are 
custodians of health records, human research ethics organisations, researchers and the community. 
The CHeReL's probabilistic linkage procedures are designed to achieve a false positive rate around 
5/1,000. A random sample of 1000 Person IDs from the linkage was selected and reviewed by the 
CHeReL, and rate of the false positives was 3/1,000. 
 
Statistical analysis 
Analysis subset 
The set of data used for analysis was obtained from linkage between CCR, NSW APDC and ClinCR data. 
Cancer notifications from the CCR were included for the first notification, with only unique first cancers 
included. Data from the CCR were available to the end of 2008. We selected cancers from July 2000 
onwards, to be consistent with APDC records which are collected by financial year. Included cancer 
notifications were merged onto the APDC to identify hospitalisations for selected cancers. Consistency 
of dates of admission, procedure, separation and death were checked in the APDC, with inconsistent 
records ignored. Episodes of care were created, to allow for transfers between hospitals within an 
admission. Admissions with a procedure of interest occurring in or after the month of cancer diagnosis 
were selected as index admissions. Procedures of interest, summarised in Appendix 1, were derived 
from work conducted with the MERU team at the Cancer Institute NSW, and supplemented by 
procedures used in Hall et al (2005).11 
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Coverage 
Coverage was examined in several ways to inform various potential uses of the data. The proportion of 
the cohort with a ClinCR record was calculated for the total cohort (population coverage for those 
diagnosed since 2000) and for those diagnosed in 2007 and 2008 (when the ClinCR was in operation). 
The proportion of the cohort diagnosed in 2007 and 2008 with a procedure of interest in a public 
hospital who have a ClinCR record was also determined, and the results tabulated by AHS. 
Completeness 
People in the ClinCR have more than one record if they received multiple occasions of treatment and/or 
multiple treatment types. Levels of missing data for each item in the collated ClinCR and dataset 
extension were therefore examined in 3 ways: 1) the number and proportion of records with data 
recorded for the item, 2) the number and proportion of persons who have any data recorded for the 
item, and 3) the number and proportion of persons for whom all records have data for the item. 
Concordance 
Concordance between items in the CCR/APDC/RBDM and duplicate items in the ClinCR was examined 
for those in the cohort with a ClinCR record. The proportion of people with the same data values across 
duplicate items was calculated. As many of the data were skewed to outliers, median and interquartile 
range (IQR) were used in reporting the differences between discordant dates. 
Internal consistency 
The number of records and persons in the collated ClinCR for whom dates appear illogical was calculated 
(e.g. date of radiotherapy before date of diagnosis), as well as the median difference (IQR) between 
illogical dates. 
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RESULTS 
Description of cohort 
We selected 37,593 first unique cancer notifications between July 2000 and December 2008 from a total 
of 40,328 cancer notifications received from the CCR. A total of 37,050 people had data recorded in the 
APDC, and 437,695 records from 37,049 people had consistent dates of admission, procedure, 
separation and death. There were 28,360 patients with an admission containing a procedure of interest 
in or after the month previous to cancer notification. 
Linked dataset 
The characteristics of the people in the ClinCR dataset and those in the study cohort are compared in 
Table 2. A flowchart for the creation of the linked dataset is shown in Figure 1. 
Table 2: Characteristics of persons in the ClinCR and study cohort 
 ClinCR 
n persons (%) 
Study cohort* 
n persons (%) 
Sex  
     Male 
     Female 
 
3,033 (55.6) 
2,418 (44.4) 
 
20,441 (54.4) 
17,152 (45.6) 
Age at diagnosis 
     0-49 
     50-59 
     60-69 
     70-79 
     80+ 
 
408 (7.5) 
791 (14.5) 
1,398 (25.6) 
1,606 (29.5) 
1,248 (22.9) 
 
2,567 (6.8) 
5,547 (14.8) 
9,696 (25.8) 
11,546 (30.7) 
8,237 (21.9) 
Country of birth 
     Australia 
     Other country 
     Missing  
 
3,519 (64.6) 
1,883 (34.5) 
50 (0.9) 
 
26,109 (69.5) 
9,992 (26.6) 
1,492 (4.0) 
Primary site of cancer 
     Colon 
     Rectosigmoid junction 
     Rectum 
     Anus 
 
3,355 (61.5) 
498 (9.1) 
1,459 (26.8) 
140 (2.6) 
 
24,172 (64.3) 
2,980 (7.9) 
9,642 (25.6) 
799 (2.1) 
Degree of spread 
     Localised 
     Regional spread 
     Distant metastases 
     Missing 
 
1,849 (33.9) 
2,147 (39.4) 
1,173 (21.5) 
283 (5.2) 
 
12,702 (33.8) 
14,718 (39.2) 
6,253 (16.6) 
3,920 (10.4) 
TOTAL 5,452 (100.0) 37,593 (100.0) 
* Based on CCR items 
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Figure 1: Flowchart of linked dataset creation  
Merge RBDM deaths → All CCR Records 
40,328 records from 39,805 people 
→ Delete ppn 46952 due to differing 
deaths in RBDM 
  ↓   
  
Clean CCR+RBDM records 
40,327 records from 39,804 people 
 
 
  ↓ ↘  
  Select CCR records after 1/7/00 
38,318 records from 37,832 people 
 Exclude CCR records before 1/7/00 
2,009 records from 1,987 people 
  ↓ ↘  
  Select first cancers 
38,071 records from 37,832 people 
 Exclude non-first cancers 
247 records from 246 people 
  ↓ ↘  
  Select unique first cancers  
37,593 records from 37,593 people 
 Exclude non-unique first cancers 
478 records from 239 people 
     
Merge APDC records 
461,793 records from 38,940 people → ↓ → 
Unmatched records 
21,768 records in APDC only 
543 people in CCR only 
  440,025 records from 37,050 people   
  ↓   
  Assess dates of admission, procedure, 
separation, death 
  
  ↓ ↘  
  Consistent admissions 
437,695 records from 37,049 people 
 Flag inconsistent admissions 
procdate < admdate (234) 
sepdate < admdate (1) 
sepdate < procdate (2,095) 
= 2,330 records 
  ↓ ↘  
  Consistent date of death 
437,275 records from 37,018 people 
 Flag people with inconsistent date of 
death 
date of death < admdate 
420 records from 31 people 
  ↓   
  Create episodes of care from multiple 
admissions 
Construct episode-level summaries 
Select first episode with a procedure of 
interest in or after month before diagnosis 
Label cohort membership: 
    In analysis cohort:  28,360 
    Not in analysis cohort:  9,233 
  
  ↓   
  Analysis cohort 
28,360 records from 28,360 people 
Tumour type 
18,749 C18: Colon 
2,280 C19: Recto-sigmoid 
7,073 C20: Rectum 
2,57 C21: Anal 
  
Merge ClinCR records 
12,968 records from 5,452 people 
→ ↓ → 
In ClinCR but not in CCR 
111 records from 31 people 
In CCR but not in ClinCR 
32,172 records from 32,172 people 
  In both CCR and ClinCR 
12,857 records from 5,421 people 
 
With procedure of interest 
10,037 records from 4,244 people 
 
Without procedure of interest 
2,820 records from 1,177 people 
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1. Data availability 
The study cohort comprised people with an incident colorectal or anal cancer diagnosed from 1 January 
2000 onwards. At the time of this analysis, data from the CCR were available to 31 December 2008. Data 
from the APDC were available to the middle of 2010, and the RBDM to the end of 2010. ClinCR data for 
2007 and 2008 were included in the analysis. 
2. Coverage of patient cohort 
99.4% of people in the ClinCR linked to a record in the cohort dataset (5,421 of 5,452 persons). While 
only 14.4% of people in the total cohort have a ClinCR record, 55.9% of people diagnosed in 2007 and 
2008 have a ClinCR record. 
Table 3: Proportion of cohort with a ClinCR record 
 Persons in cohort Persons in cohort with  
ClinCR record, n (%) 
Pre 2007 28,136 130* 
2007 4,803 2,442 (50.8) 
2008 4,654 2,849 (61.2) 
Total 2007/2008 9,457 5,291 (55.9) 
Total 37,593 5,421 (14.4) 
* Year of diagnosis >=2007 in ClinCR but discordant with linked record 
 
Proportion of cohort with a procedure of interest in a public hospital (PH) who have a ClinCR record 
78.5% of people diagnosed in 2007 and 2008 who had a procedure of interest in a public hospital have a 
ClinCR record. The coverage of the ClinCR for procedure of interest in a public hospital increased from 
72.7% for those diagnosed in 2007 to 84.7% in 2008. 
Table 4: Proportion of cohort with a procedure of interest in a PH who have a ClinCR record by year 
 Persons in cohort Persons in cohort with a 
procedure of interest  
in a PH, n (%) 
Persons in cohort with a 
procedure of interest in a PH 
with a ClinCR record, n (%) 
Pre 2007 28,136 13,042 (46.4) 81* 
2007 4,803 2,185 (45.5) 1,589 (72.7) 
2008 4,654 2,061 (44.3) 1,746 (84.7) 
Total 2007/2008 9,457 4,246 (44.9) 3,335 (78.5) 
* Year of diagnosis >=2007 in ClinCR but discordant with linked record 
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By 2008, all AHS had a ClinCR in full operation. The proportion of people who had a procedure of 
interest in a PH who have a ClinCR record is over 94% for all AHS in 2008. 
Table 5: Proportion of cohort with a procedure of interest in a PH who have a ClinCR record by AHS 
 Persons in cohort with a procedure of 
interest in a PH, 2008 only 
Persons in cohort with a procedure of 
interest in a PH with ClinCR record, n (%) 
AHS A 283 278 (98.2) 
AHS B 207 196 (94.7) 
AHS C 226 218 (96.5) 
AHS D 370 360 (97.3) 
AHS E 482 463 (96.1) 
AHS F 222 217 (97.7) 
Total 1,790 1,732 (96.8) 
 
 
 
3. Completeness of data items 
This section aims to determine the completeness of ClinCR data in terms of its usefulness for other 
analyses. For the purposes of this report, data coded as “unknown”, “not stated”, “uncertain” or as 
default dates are considered missing. Codes for data items are available in Appendix 2 and Appendix 3. 
People in the ClinCR have more than one record if they received multiple occasions of treatment and/or 
multiple treatment types. Missingness is reported below both by record and by person, but the 
denominator varies depending on whether the record can reasonably be expected to have data for a 
certain item. For example, a record relating to radiotherapy would not be expected to have information 
on chemotherapy items or hospital admissions, therefore the proportion of available data is based on 
those records relating to radiotherapy alone. 
4.1% of persons in the ClinCR dataset are treated in more than one AHS (see table 7 below). To more 
accurately determine the proportion of persons for whom at least some data are available for a 
particular item (“persons with any data”), the first AHS where a person receives treatment is credited 
with the non-missing data. All person data is reported by first AHS of presentation, unless otherwise 
stated. A breakdown of completeness of each item by AHS is available in Appendix 4 and Appendix 5. 
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Table 6: Records and persons in the ClinCR by AHS 
 n records (%) n persons (%) 
AHS A 1,517 (11.7) 473 (8.7) 
AHS B 1,629 (12.6) 577 (10.6) 
AHS C 2,625 (20.2) 954 (17.5) 
AHS D 2,367 (18.3) 1,232 (22.6) 
AHS E 2,245 (17.3) 1,395 (25.6) 
AHS F 2,585 (19.9) 821 (15.1) 
Total ClinCR 12,968 (100.0) 5,452 (100.0) 
 
Table 7: Persons in multiple AHS in the ClinCR 
 n persons (%) 
Persons in one AHS 5,230 (95.9) 
Persons in two AHS 221 (4.1) 
Persons in three AHS 1 (0.0) 
Total 5,452 (100.0) 
 
Demographic items 
All records were included in the denominator for demographic items. 
Table 8: Completeness of demographic items in the ClinCR 
 Records with data, 
n (%) 
Persons with any data,  
n (%) 
Persons with all data,  
n (%) 
Sex 12,966 (100.0) 5,450 (100.0) 5,450 (100.0) 
Year of birth 12,967 (100.0) 5,451 (100.0) 5,451 (100.0) 
Country of birth 12,876 (99.3) 5,402 (99.1) 5,392 (98.9) 
Postcode 8,015 (61.8) 3,469 (63.6) 3,329 (61.6) 
Indigenous status 10,630 (82.0) 4,058 (74.4) 3,932 (72.1) 
AMO registration number 12,732 (98.2) 5,299 (97.2) 5,230 (95.9) 
Facility code 12,921 (99.6) 5,411 (99.2) 5,405 (99.1) 
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Diagnostic items 
All records were included in the denominator for diagnostic items. ClinCR data dictionary item “laterality 
of primary cancer” was not recorded by any AHS. 
Table 9: Completeness of diagnostic items in the ClinCR 
 Records with data, 
n (%) 
Persons with any data,  
n (%) 
Persons with all data,  
n (%) 
Date of diagnosis of cancer 12,968 (100.0) 5,452 (100.0) 5,452 (100.0) 
Primary site of cancer 12,968 (100.0) 5,452 (100.0) 5,452 (100.0) 
Best basis for primary cancer 
diagnosis 
12,949 (99.9) 5,446 (99.9) 5,436 (99.7) 
Histopathological grade 10,884 (83.9) 4,654 (85.4) 4,543 (83.3) 
Morphology of cancer 12,961 (99.9) 5,450 (100.0) 5,450 (100.0) 
Morphology (ICD) version* 1,623 (12.5) 585 (10.7) 558 (10.2) 
Degree of spread of cancer 12,424 (95.8) 5,214 (95.6) 5,146 (94.4) 
* Not in ClinCR data dictionary and not requested by researchers; reported by one AHS only  
 
 
 
Staging items 
All records were included in the denominator for staging items. 
Table 10: Completeness of staging items in the ClinCR 
 Records with data, 
n (%) 
Persons with any data,  
n (%) 
Persons with all data,  
n (%) 
Cancer staging - T stage code 10,315 (79.5) 4352 (79.8) 4,238 (77.7) 
Cancer staging - N stage code 10,198 (78.6) 4,298 (78.8) 4,194 (76.9) 
Cancer staging - M stage code 10,040 (77.4) 4,213 (77.3) 4,103 (75.3) 
Staging basis 10,678 (82.3) 4,597 (84.3) 4,495 (82.4) 
Other staging systems and 
classifications1 
4,396 (33.9) 2,374 (43.5) 2,246 (41.2) 
Other stage groupings2 4,348 (33.5) 2,335 (42.8) 2,207 (40.5) 
TNM stage3 7,091 (54.7) 3,384 (62.1) 3,240 (59.4) 
TNM edition number3 3,845 (29.6) 1,332 (24.4) 1,246 (22.9) 
Best stage3 2,184 (16.8) 1405 (25.8) 1,294 (23.7) 
1 Optional item; 2 Dependent on above item 
3 Not in ClinCR data dictionary and not requested by researchers 
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Treatment items 
Treatment items in the ClinCR include those related to admissions, radiotherapy, and chemotherapy. 
ClinCR data dictionary item “treatment modality” (below), which indicates type of treatment for each 
record, was available in 3 of the 6 AHS. 
 Records with data, 
n (%) 
Persons with any data,  
n (%) 
Persons with all data,  
n (%) 
Treatment modality 6,347 (48.9) 2,760 (50.6) 2,695 (49.4) 
 
Admissions 
Records were flagged as admission records if they had a value for any of the admission items (date of 
admission, date of discharge, treatment procedure) or the item “treatment modality” indicated 
admission. These records became the denominator for admission-related items. The total number and 
proportion of admission records in the ClinCR dataset are presented below, followed by a breakdown of 
completeness by item. 
 n records (%) n persons (%) 
Total admissions 8,794 (67.8) 4,820 (88.4) 
 
 
Table 11: Completeness of treatment items in the ClinCR (admission-related) 
 Records with data, 
n (%) 
Persons with any data,  
n (%) 
Persons with all data,  
n (%) 
Date of admission 8,648 (98.3) 4,761 (98.8) 4,683 (97.2) 
Date of discharge 8,610 (97.9) 4,748 (98.5) 4,651 (96.5) 
Procedure (ICD) version1 4,422 (50.3) 2,049 (42.5) 1,705 (35.4) 
Treatment procedure for 
cancer (1)2 
8,232 (93.6) 4,787 (99.3) 4,407 (91.4) 
1 Not in ClinCR data dictionary and not requested by researchers 
2 There are 27 procedure items; this item reflects how many people have at least one procedure code recorded 
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Radiotherapy 
Records were flagged as radiotherapy records if they had a value for any of the radiotherapy items or 
the item “treatment modality” indicated radiotherapy. These records became the denominator for 
radiotherapy-related items. The total number and proportion of radiotherapy records in the ClinCR 
dataset is presented below, followed by a breakdown of completeness by item. 
 n records (%) n persons (%) 
Total radiotherapy  812 (6.3) 762 (14.0) 
 
Table 12: Completeness of treatment items in the ClinCR (radiotherapy-related) 
 Records with data, 
n (%) 
Persons with any data,  
n (%) 
Persons with all data,  
n (%) 
Date of radiotherapy start 760 (93.6) 719 (94.4) 711 (93.3) 
Date of radiotherapy end 739 (91.0) 705 (92.5) 699 (91.7) 
Radiotherapy treatment type 762 (93.8) 737 (96.7) 725 (95.1) 
Received radiation dose 700 (86.2) 682 (89.5) 668 (87.7) 
Radiation fractions 704 (86.7) 685 (89.9) 672 (88.2) 
 
 
Chemotherapy 
Records were flagged as chemotherapy records if they had a value for any of the chemotherapy items or 
the item “treatment modality” indicated chemotherapy. These records became the denominator for 
chemotherapy-related items. The total number and proportion of chemotherapy records in the ClinCR is 
presented below, followed by a breakdown of completeness by item. 
 n records (%) n persons (%) 
Total chemotherapy  3,290 (25.4) 2,469 (45.3) 
 
Table 13: Completeness of treatment items in the ClinCR (chemotherapy-related) 
 Records with data, 
n (%) 
Persons with any data,  
n (%) 
Persons with all data,  
n (%) 
Date of systemic therapy start 3,102 (94.3) 2,331 (94.4) 2,289 (92.7) 
Date of systemic therapy end 2,869 (87.2) 2,196 (88.9) 2,083 (84.4) 
Systemic therapy protocol name 3,275 (99.5) 2,457 (99.5) 2,454 (99.4) 
Number of cycles 2,921 (88.8) 2,219 (89.9) 2,131 (86.3) 
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Quality of care indicators 
All records were part of the denominator for quality of care indicators. ClinCR data dictionary item 
“Hospital Anxiety and Depression Scale” was not recorded by any AHS. 
Table 14: Completeness of quality of care items in the ClinCR 
 Records with data, 
n (%) 
Persons with any data,  
n (%) 
Persons with all data,  
n (%) 
Date of referral to cancer 
specialist 
3,708 (28.6) 2,284 (41.9) 709 (13.0) 
Date of consultation with cancer 
specialist 
5,901 (45.5) 3,209 (58.9) 1,648 (30.2) 
Date of decision to treat 844 (6.5) 618 (11.3) 143 (2.6) 
Date of first clinical trials 
enrolment 
451 (3.5) 132 (2.4) 107 (2.0) 
Date of first multidisciplinary 
team consultation (MDT) 
3,707 (28.6) 1,254 (23.0) 1,184 (21.7) 
Date of referral to palliative care 3,657 (28.2) 1,157 (21.2) 1,082 (19.8) 
Performance status at diagnosis 3,506 (27.0) 1,386 (25.4) 1,283 (23.5) 
Psycho-social referral to 9,657 (74.5) 3,786 (69.4) 3,663 (67.2) 
Date of death 4,174 (32.2) 1,305 (23.9) 1,240 (22.7) 
Cause of death 656 (5.1) 376 (6.9) 344 (6.3) 
 
 
NSW Oncology Group Colorectal Extension  
Colorectal extension data were available for two AHS only, labeled AHS X and AHS Y below. Any record 
with a value for any extension item became part of the denominator for calculating completeness of 
extension items. Extension data dictionary items “date of resection”, “site of first recurrence”, and “date 
of first recurrence” were not provided by either AHS.  
 n records  
(% of records in ahs) 
n persons  
(% of persons in ahs) 
AHS X XXXX (92.7) XXXX (92.4) 
AHS Y XXXX (54.3) XXXX (52.1) 
Total extension  3,413 (26.3) 1,908 (35.0) 
* Blacked out to preserve AHS identity 
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Table 15: Completeness of NSW Oncology Group colorectal extension items 
 Records with data, 
n (%) 
Persons with any 
data, n (%) 
Persons with all 
data, n (%) 
Presentation 2,641 (77.4) 1,384 (72.5) 1,371 (71.9) 
Method of surgery 1,817 (53.2) 1027 (53.8) 1,023 (53.6) 
Level of rectal cancer 434 (12.7) 186 (9.7) 181 (9.5) 
Residual tumour status 2,610 (76.5) 1,452 (76.1) 1,445 (75.7) 
Radial resection margin 1,181 (34.6) 664 (34.8) 656 (34.4) 
Lymphovascular invasion 2,637 (77.3) 1,474 (77.3) 1,469 (77.0) 
Number of lymph nodes examined 2,751 (80.6) 1,534 (80.4) 1,529 (80.1) 
Number of lymph nodes involved 2,760 (80.9) 1,539 (80.7) 1,532 (80.3) 
Mismatch repair deficiency (MMRD) 2,699 (79.1) 1,501 (78.7) 1,496 (78.4) 
Perineural invasion* 2,722 (79.8) 1,509 (79.1) 1,503 (78.8) 
* Not in extension data dictionary and not requested by researchers; collected by both AHS 
 
 
One AHS collected a number of additional colorectal items, however these are not presented in this 
report.  
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4. Concordance with other datasets for duplicate items 
Data for items in the CCR, APDC and RBDM were compared to data in duplicate items in the ClinCR. 
While there is only one record per person in the cohort dataset, there are multiple records per person in 
the ClinCR dataset. Records were considered to be concordant if data from an item in the CCR/ APDC/ 
RBDM matched at least one ClinCR record for the same person, or if both item values were missing. The 
difference between mismatching dates were calculated based on the closest ClinCR date. Dates within 
two days of date of death and one month of date of diagnosis were considered concordant.  
Table 16: Concordance of items between the ClinCR and other datasets 
 Discordant (%),  
mismatch 
Discordant (%), 
one missing 
Concordance 
(%) 
Days difference, 
median (IQR)  
Sex (CCR) 0.1 0.0 99.9  
Sex (APDC) 0.1 0.0 99.9  
Age at diagnosis (CCR) 2.1 0.0 97.8 4 (3) years 
Indigenous status (CCR) 0.4 25.8 73.7  
Indigenous status (APDC) 0.3 25.2 74.5  
Country of birth1 (CCR) 1.3 3.7 95.0  
Country of birth1 (APDC) 25.3 1.9 72.8  
Postcode (CCR) 3.1 36.5 60.5  
Postcode (APDC) 2.3 38.1 59.6  
Area health service (CCR) 2.4 21.5 76.1  
Cancer site2 (CCR) 10.6 0.0 89.4  
Morphology (CCR) 19.1 0.0 80.9  
Degree of spread (CCR) 22.2 9.1 68.7  
Date of diagnosis (CCR) 4.3 0.0 95.7 3 (2) months3 
Date of admission (APDC) 11.2 11.0 77.7 2 (7) 
Date of discharge (APDC) 12.9 11.3 75.7 10 (18) 
Date of death (CCR) 0.2 16.6 83.1 10 (21)4 
Date of death (RBDM) 0.5 16.0 83.5 10 (14)4 
1 Matching by country region (first two digits of country code) 
2 Matching by sub-categories of site, colon (C18), rectosigmoid (C19), rectum (C20), anus (C21) 
3 For date of diagnosis > 2006  
4 For matching hospital and procedure of interest or matching hospital and ClinCR date within CCR date 
 
Other closely related variables between datasets include best basis of diagnosis (CCR) and best basis for 
primary cancer diagnosis (ClinCR), and degree of spread (CCR) and TNM staging (ClinCR).  
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5. Internal consistency of ClinCR items 
The number of records and persons with illogical dates are presented in the table below. The size of the 
discrepancies are reported as median values in days. Illogical dates were flagged according to ClinCR 
data dictionary guidelines. Dates within two days of date of death were not considered illogical. 
Table 17: Internal consistency of date items in the ClinCR  
 < date of diagnosis, 
records (persons) 
Days difference, 
median (IQR) 
> date of death, 
records (persons) 
Days difference, 
median (IQR) 
Date of admission 1,495 (1,449) 2 (5) 4(2) 507 (545) 
Date of discharge 110 (102) 14 (24) 5 (3) 245 (554) 
Date of radiotherapy start 3 (3) 94 (240)   
Date of radiotherapy end 2 (2) 100 (194)   
Date of systemic therapy start 19 (19) 34 (105) 1 (1) 223 (0) 
Date of systemic therapy end 18 (18) 68 (108) 13 (10) 75 (41) 
Date of referral to specialist   2 (2) 174 (116) 
Date of specialist consultation 1,074 (908) 10 (19) 3 (3) 116 (228) 
Date of decision to treat 9 (8) 9 (7)   
Date of MDT 94 (41) 13 (46) 4(4) 17 (304) 
Date of referral to palliative care 33 (17) 14 (28) 1 (1) 7 (0) 
 > date of systemic 
therapy end 
 < date of specialist 
consultation 
 
Date of systemic therapy start 10 (10) 213 (49)   
Date of decision to treat   89 (63) 7 (6) 
 
Some of the discrepancies above will be a result of incorrect recording of data values. Others may be 
illogical but still accurate. The majority of people in the ClinCR datasets (72.7%) did not have any illogical 
dates recorded (see table below). 
Table 18: Records and persons with illogical date flags in the ClinCR 
 n records (% of ClinCR) n persons (% of ClinCR) 
1 flag 1,690 (13.0) 1,486 (27.3) 
2 flags 583 (4.5) 596 (10.9) 
3 flags 31 (0.2) 31 (0.6) 
4 flags 10 (0.1) 9 (0.2) 
Total 2,314 (17.8) 1,998 (36.6) 
Total ClinCR 12,968 (100.0) 5,452 (100.0) 
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6. Feasibility of developing surgical indicators using Clinical Cancer Registry data 
Indicator Feasible Numerator Needs 
ClinCR/DE? 
Available n 
(%) 
Denominator Needs 
ClinCR/DE? 
Available 
n 
Short-term surgical outcome 
measures 
       
30-day mortality Yes Date of death (from CCR or 
RBDM) 
No 100% All patients receiving 
surgery 
No 28,360 
Proportion of patients presenting to 
emergency department within 28 days 
of discharge from hospital 
No Data from Emergency 
Department Data Collection for 
patients presenting to selected 
public EDs 
No 100% Patients resident near a 
hospital that supplies 
EDDC data 
No ? 
Proportion of patients with an 
unplanned readmission to hospital 
within 28 days of discharge 
Yes Date of next admission within 28 
days 
No 100% All patients receiving 
surgery 
No 28,360 
Proportion of patients with an 
unplanned return to theatre  
No Return to theatre variable on 
APDC is not consistently 
completed across hospitals 
  All patients receiving 
surgery 
No 28,360 
Proportion of patients developing an 
anastomotic leak  
No 'Complications' may be able to be 
detected 
  All patients receiving 
surgery 
No 28,360 
Proportion of patients developing a 
wound infection  
Yes Subsequent admissions with 
wound infection codes (to be 
defined) 
No 100% All patients receiving 
surgery 
No 28,360 
Proportion of patients developing 
cardiopulmonary complication 
Yes Subsequent admissions with 
cardio-pulmonary codes (to be 
defined) 
No 100% All patients receiving 
surgery 
No 28,360 
Proportion of patients developing a 
deep vein thrombosis 
Yes Subsequent admissions with 
DVT codes (to be defined) 
No 100% All patients receiving 
surgery 
No 28,360 
Proportion of patients with prolonged 
length of stay for the relevant 
Diagnostic Related Group (DRG) 
Yes Episode length of stay greater 
than DRG length of stay 
No 100% All patients receiving 
surgery 
No 28,360 
Proportion of patients with length of 
stay greater than 21 days 
Yes Episode length of stay greater 
than 21 days 
No 100% All patients receiving 
surgery 
No 28,360 
Longer term outcome measures        
1-year and 3-year cancer-specific/all 
cause survival proportions 
Yes Date of death (from CCR or 
RBDM) 
No 100% All patients receiving 
surgery 
No 28,360 
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Indicator Feasible Numerator Needs 
ClinCR/DE? 
Available n 
(%) 
Denominator Needs 
ClinCR/DE? 
Available 
n 
Proportion of patients undergoing 
resection for rectal cancer who have a 
permanent stoma formed 
Yes Rectal cancer patients 
undergoing abdominoperineal 
excision (code: 32039-00) 
No 100% All rectal cancer patients 
receiving surgery 
No C19: 
2,280 
C20: 
7,073 
 
Evidence-based or care process 
measures 
       
Proportion of patients discussed at a 
multi-disciplinary team (MDT) meeting 
Yes: if missing 
MDT date is 
an indication 
of no MDT 
Date of MDT Yes 1,035 (24.4%) All patients with ClinCR 
records that link to CCR-
APDC records 
Yes: ClinCR 4,244 
Proportion of patients with a pre-
operative CT scan 
No Not measured in ClinCR / DE   All patients with ClinCR 
records that link to CCR-
APDC records 
Yes: ClinCR 4,244 
Proportion of patients with lower rectal 
cancer with a pre-operative pelvic MRI 
scan 
No Not measured in ClinCR / DE   All patients with ClinCR 
records that link to CCR-
APDC records 
Yes: ClinCR 4,244 
Proportion of patients with documented 
cancer stage 
Yes Extent of disease 
 
No 100%  
[Note: 5.3% 
with unknown 
stage(=9)] 
All patients receiving 
surgery 
No 28,360 
  Summary TNM stage 
Constructed TNM 
Summary or constructed TNM 
Yes 
Yes 
Yes 
2,646 (62.4%) 
3,082 (72.6%) 
3,496 (82.4%) 
All patients with ClinCR 
records that link to CCR-
APDC records 
Yes 4,244 
Proportion of patients having any 
surgical intervention (including stent) 
No Only have admissions to NSW 
hospitals. There are low rates of 
surgery for LHDs near ACT and 
other NSW borders, indicating 
cross-border hospital data are 
needed 
  All patients in CCR No 37,593 
Proportion of patients with rectal cancer 
seen pre-operatively by a stoma 
therapist 
No Not measured in ClinCR / DE      
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Indicator Feasible Numerator Needs 
ClinCR/DE? 
Available n 
(%) 
Denominator Needs 
ClinCR/DE? 
Available 
n 
Proportion of patients having minimally-
invasive surgery 
No. Can 
obtain 
proportion of 
surgery that 
was minimally 
invasive 
Procedures performed 
laparoscopically, or with stent 
only 
No 100% All patients receiving 
surgery 
No 28,360 
Proportion of patients with apical lymph 
node status recorded 
No Not measured in ClinCR / DE      
Proportion of patients with 
circumferential margin status recorded 
Yes Patients with radial margin status 
recorded 
Yes: DE 621 (29.7%) Patients with DE Yes: DE 2,088 
Proportion of patients with extramural 
vascular invasion status recorded 
Yes Patients with lymphovascular 
invasion recorded 
Yes: DE 1,353 (64.8%) Patients with DE Yes: DE 2,088 
Proportion of patients with pathological 
stage recorded 
Yes (T-stage, N-stage, M-stage all 
present OR TNM-stage present 
OR other stage present) AND 
staging basis is recorded 
 
Yes: DE 2,386 (56.2%) All patients with ClinCR 
records that link to CCR-
APDC records 
Yes: ClinCR 4,244 
Proportion of patients receiving pre-
operative thrombo-embolism 
prophylaxis 
No Not measured in ClinCR / DE      
Proportion of patients receiving pre-
operative antibiotic prophylaxis 
No Not measured in ClinCR / DE      
Proportion of patients having Total 
Mesorectal Excision (TME) for lower 
rectal cancer 
No TME not recorded in any dataset      
Proportion of patients receiving 
adjuvant chemotherapy for lymph node 
positive colon cancer within 8 weeks of 
surgery 
Yes Patients with a first date of  
chemotherapy received 
Yes: ClinCR  751 (67.0%) Colon cancer (CCR C18) 
Lymph node positive 
(ClinCR: N-stage=1,2,3) 
Surgery (APDC) 
Yes: ClinCR 1,121 
30 
 
Indicator Feasible Numerator Needs 
ClinCR/DE? 
Available n 
(%) 
Denominator Needs 
ClinCR/DE? 
Available 
n 
Proportion of patients receiving 
neoadjuvant/adjuvant radiotherapy for 
locally advanced, lower rectal cancer 
Yes All patients, assuming that no 
date of radiotherapy means no 
radiotherapy was received 
Yes: ClinCR 108 (100%) Rectal cancer (CCR C20) 
Locally advanced  
(T-stage=2,3)  
[Lower rectal cancer, 
≤10cm from anal verge] 
OR [location of rectal 
cancer=low (SSW)] 
No 
Yes: ClinCR 
 
Yes: DE 
 
108 
Proportion of patients receiving colonic 
pouch reconstruction after low anterior 
resection for T3 rectal cancer less than 
10cm from anal verge 
Yes Patients receiving subsequent 
colonic pouch reconstruction 
(code 32029-00: Construction of 
colonic reservoir) 
No 100% Rectal cancer (CCR C20) 
T-stage=3 
[Lower rectal cancer, 
≤10cm from anal verge] 
OR [location of rectal 
cancer=low (SSW)] 
Low anterior resection 
(APDC: 32025-00, 32026-
00, 32028-00)) 
No 
Yes: ClinCR 
Yes: DE 
 
 
 
No 
83 
Proportion of patients with 12 or more 
lymph nodes examined 
Yes "Number nodes examined" 
variable 
Yes: DE 1,399 (67.0%) Patients with DE Yes: DE 2,088 
Proportion of patients enrolled in a 
clinical trial 
Yes Date of first clinical trial 
enrollment 
Yes 102 (2.4%) All patients with ClinCR 
records that link to CCR-
APDC records 
Yes: ClinCR 4,244 
Proportion of patients within 31-day 
target for time from decision to treat to 
commencement of treatment 
Yes Difference between date of 
decision to treat and first 
chemotherapy or radiotherapy 
treatment [Note: substantial 
number of negative differences] 
Yes  443 (10.4%)  All patients with ClinCR 
records that link to CCR-
APDC records 
Yes: ClinCR 4,244 
Proportion of patients within 62-day 
target for time from initial referral to 
commencement of treatment 
Yes Difference between date of 
referral to cancer specialist and 
first chemotherapy or 
radiotherapy treatment 
[Note: substantial number of 
negative differences] 
Yes 1,438 (33.9%) All patients with ClinCR 
records that link to CCR-
APDC records 
Yes: ClinCR 4,244 
Proportion of major colorectal 
resections undertaken between 8pm 
and 8am 
No Time of procedure is not 
recorded on any data 
  All patients receiving 
surgery 
No 28,360 
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DISCUSSION 
The ClinCR dataset provides a range of data on cancer staging, clinical treatment and care processes that 
adds valuable information to other routinely collected data sources. The additional measures collected 
in the dataset extension provide more detailed information about colorectal-specific care and 
outcomes. While there are limitations in the coverage and quality of the ClinCR and extension data, 
without these datasets the development of population-based surgical indicators from routinely 
collected sources would be greatly limited. 
Fifty-six percent of colorectal cancer cases registered in the CCR in 2007 and 2008 have a corresponding 
ClinCR record. The scope of collection of the current ClinCR means that cases of cancer in NSW residents 
who are diagnosed or treated solely in private facilities in NSW, or in public facilities in Greater Southern 
(GS) and Greater Western (GW) Area Health Services, or who are treated outside of NSW, are not 
included in the dataset. However, coverage for those with a procedure of interest in a public hospital in 
2008, when all AHS had a well-established ClinCR, is over 94% for all AHS (see Table 5). There is a trend 
for increased coverage of all patients by year (see Table 3-4), which is also evident in the dramatic 
increase in coverage from the first year of operation to the subsequent year for the last AHS to establish 
a ClinCR. Even with the limitations of collection, those in the ClinCR appear to be largely representative 
of all patients treated for colorectal cancer in the time period (see Table 2). Nonetheless, the calculation 
of accurate rates of treatment and adherence to evidence-based guidelines is restricted by coverage of 
public facilities only, and by the exclusion of the two AHS (GS and GW). 
Completeness is important for determining which items are reliable and provide useful information. 
Demographic and diagnostic items in the ClinCR have a high rate of completeness overall, with most 
non-optional items having data for over 95% of people (see Table 8-9). The four non-optional staging 
items provide complete data for 77% to 84% of people (see Table 10). Completeness of treatment items 
in the ClinCR is also mostly high. While treatment modality was specified in only 49% of records, all 
admission-related, radiotherapy and chemotherapy dates have data for 91% or more records except 
date of chemotherapy end (see Table 11-13). Specific items relating to treatment type or delivery range 
in completeness from 86% to 99%. 
There is less information recorded for items relating to care, such as dates of referrals and consultations 
(see Table 14). For all of these items except psycho-social referral, less than 60% of people have data. 
However, it is difficult to determine whether the occasions of care did not take place or the data are 
simply missing. While many items in the ClinCR have a default option to code when the value of an item 
is unknown, it is hard to know whether these are used reliably. Similarly, some AHS have a higher 
number of records “flagged” as relating to a treatment event, but with lower completeness of individual 
treatment items. This variation may indicate that some AHS have different rules around the creation of 
treatment event records when specific data values are unknown. It is also an important consideration in 
the interpretation of rates of treatment and adherence to evidence-based guidelines. 
Fifteen items in the ClinCR are duplicated or are closely related to items in other sources that formed 
our linked dataset (not including specific name and address identifiers). Mismatching values make up 3% 
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or less of data for all duplicate demographic items except for one country of birth item (ClinCR to APDC) 
(see Table 16). The lower rates of concordance between staging items, diagnostic items and admission-
related dates are not ideal, but the size of the date differences are generally not large. Further 
investigation is needed to determine whether differences are inaccuracies or due to other reasons such 
as subsequent colorectal cancer diagnoses.  
Date items in the ClinCR are mainly internally consistent. Overall, 82% of records do not contain any sets 
of illogical dates, and most of these records have less than two illogical date flags. Illogical date flags 
more often arise between dates of treatment or care and date of diagnosis, although there are greater 
median discrepancies between dates of treatment or care and date of death (see Table 17). While some 
discrepancies may be the result of incorrect recording, others will be accurate despite their unlikeliness. 
Using routinely collected data to improve the timeliness and reduce the resource-intensiveness of 
clinical audit against best practice guidelines is only feasible if the data are able to provide enough 
information from which to develop indicators of outcome or evidence-based care. Of 34 proposed 
surgical indicators that were developed by an international collaboration, 21 could feasibly be calculated 
from items in the linked dataset (62%). ClinCR or extension items are required for 12 of these 21 
indicators. However, six of these indicators rely on data from the colorectal dataset extension, which 
currently is only collected in two AHS. Within these AHS, completeness of dataset extension items range 
from 53% to 81% for core items (see Table 15).  
Although the timeliness of construction of a linked dataset to enable monitoring of the uptake of 
evidence-based guidelines is limited by factors such as the availability of current cancer registration data 
and the time taken to receive and harmonise data from different datasets, there appears to be potential 
to conduct patterns of care studies using data routinely collected in NSW. Integration of the ClinCR into 
the CCR from July 2012 will facilitate this work. 
Recommendations 
The following recommendations arise solely from the analysis of data available for this report: 
• To increase the coverage of the ClinCR to private facilities to enable better estimates of rates of 
treatment. 
• To concentrate resources on data items that are unique to the ClinCR and not readily available from 
other existing data sources. 
• To determine the accuracy of recording of items where doubt exists over whether data are missing 
or care or treatment did not occur e.g. through clinical record audit of a subset of the population. 
• To standardise the recording of variables in each individual AHS ClinCR for ease of use. 
• To increase the collection of the ClinCR and dataset extension to all AHS where they are not 
currently in operation. 
• Research projects that require ClinCR data should take into consideration the coverage and 
completeness of records and should be restricted to patients diagnosed after 2007. 
• Further assessment of the quality of ClinCR data for other tumour types for research purposes is 
recommended. 
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Appendix 1: Surgical procedures used to identify index admissions 
ICD-10-AM code Description 
32000-00 Limited excision of large intestine with formation of stoma 
32000-01 Right hemicolectomy with formation of stoma 
32003-00 Limited excision of large intestine with anastomosis 
32003-01 Right hemicolectomy with anastomosis 
32004-00 Sub-total colectomy with formation of stoma 
32004-01 Extended right hemicolectomy with formation of stoma 
32005-00 Subtotal colectomy with ileosigmoid anastomosis 
32005-01 Extended right hemicolectomy with anastomosis 
32006-00 Left hemicolectomy with anastomosis 
32006-01 Left hemicolectomy with formation of stoma 
32009-00 Total colectomy with ileostomy 
32012-00 Total colectomy with ileorectal anastomosis 
32015-00 Total proctocolectomy with ileostomy 
32024-00 High restorative anterior resection of rectum with intraperitoneal anastomosis 
32025-00 Low restorative anterior resection of rectum with extraperitoneal anastomosis 
32026-00 Low restorative anterior resection of rectum with coloanal anastomosis 
32028-00 Ultra low restorative anterior resection of rectum with sutured coloanal anastomosis 
32030-00 Rectosigmoidectomy with formation of stoma 
32039-00 Abdominoperineal proctectomy 
32047-00 Perineal proctectomy 
32051-00 Total proctocolectomy with ileo-anal anastomosis 
32051-01 Total proctocolectomy with ileo-anal anastomosis and formation of temporary ileostomy 
32060-00 Closure of ileostomy with restoration of bowel continuity, with resection 
32112-00 Perineal rectosigmoidectomy 
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ICD-10-AM code Description 
43993-01 Resection of large intestine or rectum for Hirschsprung's disease, with definitive anastomosis 
32051-03 Total proctocolectomy with ileorectal anastomosis and formation of temporary ileostomy 
43804-00 Resection of intestine for malrotation 
43804-01 Resection of intestine for malrotation, with formation of stoma 
43813-00 Repair of complicated meconium ileus with anastomosis 
43813-01 Repair of complicated meconium ileus with stoma formation 
43816-00 Resection of intestine for meconium ileus with anastomosis 
43816-01 Resection of intestine for meconium ileus with stoma formation 
43828-00 Resection of intestine for acute neonatal necrotising enterocolitis with anastomosis 
43828-01 Resection of intestine for acute neonatal necrotising enterocolitis, with formation of stoma 
43834-00 Resection of stricture of large intestine with anastomosis 
43834-01 Resection of stricture of large intestine with formation of stoma 
43936-00 Resection of intussusception, paediatric 
43990-00 Resection of large intestine or rectum for Hirschsprung's disease, with stoma formation 
90336-01 Isolation of segment of large intestine for interposition 
Supplementary procedures used in Hall et al, ANZ J Surg, 200511  
32099-00 Per anal submucosal excision of rectal tumour 
32105-00 Per anal full thickness excision of anorectal tumour 
32108-00 Trans-sphincteric excision of rectal tumour 
43816-02 Repair of colonic atresia 
43993-01 Resection of large intestine or rectum for Hirschsprung's disease, with definitive anastomosis 
43993-02 Resection of large intestine or rectum for Hirschsprung's disease, with definitive anastomosis and stoma formation or revision 
43996-00 Total colectomy for Hirschsprung's disease, with definitive anastomosis 
90341-00 Excision of other rectal lesion 
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Appendix 2: Data Dictionary for collated ClinCR 
Item Values 
All date items DD/MM/YYYY 
Default date 01/01/1850 if date is unknown 
Sex 1 - Male 
2 - Female 
9 - Not stated 
Year of birth NNNN 
Country of birth NNNN 
Standard Australian Classifications of Countries (SACC) 
Postcode NNNN 
9990 - Overseas 
Indigenous status 1 - Aboriginal 
2 - Torres Strait Islander 
3 - Both Aboriginal and Torres Strait Islander 
4 - Neither Aboriginal or Torres Strait Islander 
8 - Declined to respond 
9 - Not stated/inadequately described 
AMO registration number Alphanumeric 
Facility code ANNN 
Date of diagnosis of cancer DD/MM/YYYY 
Primary site of cancer ICD-10-AM codes 
Best basis for primary cancer 
diagnosis 
1 - Histopathology 
2 - Cytology 
3 - Other 
9 - Unknown 
Histopathological grade 1 - Grade 1, Well differentiated, differentiated, NOS 
2 - Grade 2, Moderately differentiated, moderately well differentiated, 
intermediate differentiation 
3 - Grade 3, Poorly differentiated 
4 - Grade 4, Undifferentiated, anaplastic 
5 - T-cell (Lymphomas and leukaemias) 
6 - B-cell, Pre-B, B-Precursor (Lymphomas and leukaemias) 
7 - Null cell, Non T- non B (Lymphomas and leukaemias) 
8 - Natural killer cell (Lymphomas and leukaemias) 
9 - Grade/Differentiation unknown 
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Item Values 
Morphology of cancer ICD-O-3 codes 
Degree of spread of cancer 1 - Localised to the tissue of origin 
2 - Invasion of adjacent tissue or organs 
3 - Regional lymph nodes 
4 - Distant metastases 
5 - Not applicable 
9 - Not known 
Cancer staging - T stage code X - Primary tumour cannot be assessed or is unknown 
0 - No evidence of primary tumour 
IS - Carcinoma in situ 
88 - TNM stage not applicable 
Staging 1 through 4D 
Cancer staging - N stage code X - Regional lymph nodes cannot be assessed or are unknown 
0 - Nodes assessed, no evidence of regional lymph node metastasis 
88 - TNM stage not applicable 
Staging 1 through 3C 
Cancer staging - M stage code X - Presence of distant metastases cannot be assessed or is unknown 
0 - No known distant metastasis 
88 - TNM stage not applicable 
Staging 1 though 1C 
Staging basis 1 - Pathological 
2 - Clinical 
9 - Unknown 
Other staging systems and 
classifications 
(Relevant to colorectal cancer) 
1 - TNM Classification of Malignant Tumours 
4 - Australian Clinico-Pathological Staging (ACPS) System 
5 - Duke’s for colorectal cancers 
23 - Modified Astler-Coller classification for colorectal 
99 - Not for primary collection or unknown 
Other stage groupings Staging per above systems/classifications 
Treatment modality 1 - Surgery 
2 - Radiotherapy 
3 - Medical Oncology and Haematology 
4 - Diagnostic 
5 - Admitted/Other 
Treatment procedure for 
cancer (1 through 27) 
ICD-10-AM codes 
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Item Values 
Radiotherapy treatment type 0 - No radiotherapy treatment given 
1 - External beam radiation 
2 - Brachytherapy 
3 - Unsealed radioisotopes 
9 - Radiotherapy administered but method not stated 
Received radiation dose NN in Grays (Gy) 
0 - No radiation therapy was administered 
9999 - Radiation therapy was administered but dose unknown 
Radiation fractions NN 
Systemic therapy protocol 
name 
eviQ ID where possible, CI-SCaT ID where no equivalent 
0000 - No treatment 
9999 - Unknown 
Number of cycles of systemic 
therapy 
NN 
0 - Did not access planned cycles 
98 - Not applicable 
99 - Unknown 
Performance status at 
diagnosis 
0 - ECOG 0, Fully active, able to carry on all pre-disease performance without 
restriction 
1 - ECOG 1, Restricted in physically strenuous activity but ambulatory and able 
to carry out work of a light or sedentary nature e.g. light house work 
2 - ECOG 2, Ambulatory and capable of all selfcare but unable to carry out any 
work activities. Up and about >50% of waking hours 
3 - ECOG 3, Capable of only limited selfcare, confined to bed or chair >50% of 
waking hours 
4 - ECOG 4, Completely disabled. Cannot carry on any selfcare. Totally confined 
to bed or chair 
9 - Unknown 
Psycho-social referral to 0 - Not indicated 
1 - Psychiatrist 
2 - Psychologist 
3 - Social worker 
4 - Specialist nurse / nurse counsellor 
5 - Cancer support group or volunteer support group 
7 - Counsellor / bereavement counsellor 
8 - Pastoral care / chaplain / clergy / spiritual advisor 
9 - Community service 
Cause of death ICD-10-AM site codes 
6 - Non-cancer death 
7 - Died, cause unknown 
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Appendix 3: Data Dictionary for collated extension items 
Item Values 
Presentation 0 - Asymptomatic screening (FOBT) 
1 – Symptoms of bowel cancer 
2 - Emergency due to obstruction, perforation (with abscess/peritonitis), 
excessive bleeding or in conjunction with resuscitation 
9 - Unknown 
Method of surgery 0 - Open 
1 - Laparoscopic / laparoscopic assisted 
2 - Laparoscopic converted to open 
3 - Local excision e.g. Transanal endoscopic microsurgery (TEMS) 
8 - Other method of surgery 
9 - No surgery 
Level of rectal cancer NN 
cm from anal verge 
Residual tumour status 0 - No residual tumour (R0) 
1 - Microscopic residual (R1) 
2 - Macroscopic residual (R2) 
9 - Residual status is unknown (RX) 
Radial resection margin NN 
Lymphovascular invasion 0 - No 
1 - Yes 
9 - Unknown 
Number of lymph nodes 
examined 
NN 
99 – Nodes removed but number of nodes unknown/not stated  
Number of lymph nodes 
involved 
NN 
98 – No nodes examined 
99 – Unknown if nodes are positive or negative 
Mismatch repair deficiency 
(MMRD) 
0 - No Staining (abnormal) 
1 - Staining (normal) 
2 - Not Done 
Perineural invasion 0 - No invasion 
1 - Invasion 
8 - Invasion not assessed 
9 - Unknown 
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Appendix 4: Completeness of ClinCR data by AHS 
 
Demographic items 
 
Sex 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 1,516 (99.9) 472 (99.8) 472 (99.8) 
AHS B 1,628 (99.9) 576 (99.8) 576 (99.8) 
AHS C 2,625 (100.0)  954 (100.0)  954 (100.0) 
AHS D 2,367 (100.0) 1,232 (100.0) 1,232 (100.0) 
AHS E 2,245 (100.0) 1,395 (100.0) 1,395 (100.0) 
AHS F 2,585 (100.0) 821 (100.0) 821 (100.0) 
Total 12,966 (100.0) 5,450 (100.0) 5,450 (100.0) 
 
Year of birth 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 1,517 (100.0) 473 (100.0) 473 (100.0) 
AHS B 1,628 (99.9) 576 (99.8) 576 (99.8) 
AHS C 2,625 (100.0) 954 (100.0) 954 (100.0) 
AHS D 2,367 (100.0) 1,232 (100.0) 1,232 (100.0) 
AHS E 2,245 (100.0) 1,395 (100.0) 1,395 (100.0) 
AHS F 2,585 (100.0) 821 (100.0) 821 (100.0) 
Total 12,967 (100.0) 5,451 (100.0) 5,451 (100.0) 
 
Country of birth 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 1,517 (100.0) 473 (100.0) 470 (99.4) 
AHS B 1,618 (99.3) 573 (99.3) 572 (99.1) 
AHS C 2,582 (98.4) 932 (97.7) 929 (97.4) 
AHS D 2,349 (99.2) 1,221 (99.1) 1,219 (98.9) 
AHS E 2,227 (99.2) 1,384 (99.2) 1,384 (99.2) 
AHS F 2,583 (99.9) 819 (99.8) 818 (99.6) 
Total 12,876 (99.3) 5,402 (99.1) 5,392 (98.9) 
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Postcode 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 1,517 (100.0) 473 (100.0) 466 (98.5) 
AHS B 1,629 (100.0) 577 (100.0) 572 (99.1) 
AHS C 2,624 (100.0) 953 (99.9) 934 (97.9) 
AHS D 0 (0.0) 43 (3.5) 0 (0.0) 
AHS E 2,245 (100.0) 1,395 (100.0) 1,357 (97.3) 
AHS F 0 (0.0) 28 (3.4) 0 (0.0) 
Total 8,015 (61.8) 3,469 (63.6) 3,329 (61.6) 
 
Indigenous status 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 1,512 (99.7) 469 (99.2) 462 (97.7) 
AHS B 1,622 (99.6) 574 (99.5) 570 (98.8) 
AHS C 2,559 (97.5) 917 (96.1) 902 (94.5) 
AHS D 2,346 (99.1) 1,218 (98.9) 1,195 (97.0) 
AHS E 12 (0.5) 62 (4.4) 9 (0.6) 
AHS F 2,579 (99.8) 818 (99.6) 794 (96.7) 
Total 10,630 (82.0) 4,058 (74.4) 3,932 (72.1) 
 
AMO registration number 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 1,511 (99.6) 472 (98.9) 469 (99.2) 
AHS B 1,592 (97.7) 575 (99.7) 548 (95.0) 
AHS C 2,561 (97.6) 909 (95.3) 894 (93.7) 
AHS D 2,367 (100.0) 1,232 (100.0) 1,223 (99.3) 
AHS E 2,117 (94.3) 1,290 (92.5) 1,282 (91.9) 
AHS F 2,584 (100.0) 821 (100.0) 814 (99.1) 
Total 12,732 (98.2) 5,299 (97.2) 5,230 (95.9) 
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Facility code 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 1,517 (100.0) 473 (100.0) 473 (100.0) 
AHS B 1,627 (99.9) 577 (100.0) 574 (99.5) 
AHS C 2,580 (98.3) 913 (95.7) 911 (95.5) 
AHS D 2,367 (100.0) 1,232 (100.0) 1,231 (99.9) 
AHS E 2,245 (100.0) 1,395 (100.0) 1,395 (100.0) 
AHS F 2,585 (100.0) 821 (100.0) 821 (100.0) 
Total 12,921 (99.6) 5,411 (99.2) 5,405 (99.1) 
 
 
 
Diagnostic items 
 
Date of diagnosis of cancer 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 1,517 (100.0) 473 (100.0) 473 (100.0) 
AHS B 1,629 (100.0) 577 (100.0) 577 (100.0) 
AHS C 2,625 (100.0) 954 (100.0) 954 (100.0) 
AHS D 2,367 (100.0) 1,232 (100.0) 1,232 (100.0) 
AHS E 2,245 (100.0) 1,395 (100.0) 1,395 (100.0) 
AHS F 2,585 (100.0) 821 (100.0) 821 (100.0) 
Total 12,968 (100.0) 5,452 (100.0) 5,452 (100.0) 
 
Primary site of cancer 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 1,517 (100.0) 473 (100.0) 473 (100.0) 
AHS B 1,629 (100.0) 577 (100.0) 577 (100.0) 
AHS C 2,625 (100.0) 954 (100.0) 954 (100.0) 
AHS D 2,367 (100.0) 1,232 (100.0) 1,232 (100.0) 
AHS E 2,245 (100.0) 1,395 (100.0) 1,395 (100.0) 
AHS F 2,585 (100.0) 821 (100.0) 821 (100.0) 
Total 12,968 (100.0) 5,452 (100.0) 5,452 (100.0) 
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Best basis for primary cancer diagnosis 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 1,517 (100.0) 473 (100.0) 472 (99.8) 
AHS B 1,628 (99.9) 577 (100.0) 576 (99.8) 
AHS C 2,609 (99.4) 950 (99.6) 944 (99.0) 
AHS D 2,367 (100.0) 1,232 (100.0) 1,230 (99.8) 
AHS E 2,243 (99.9) 1,393 (99.9) 1,393 (99.9) 
AHS F 2,585 (100.0) 821 (100.0) 821 (100.0) 
Total 12,949 (99.9) 5,446 (99.9) 5,436 (99.7) 
 
Histopathological grade 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 1,254 (82.7) 381 (80.5) 374 (79.1) 
AHS B 1,386 (85.1) 488 (84.6) 481 (83.4) 
AHS C 2,010 (76.6) 737 (77.3) 708 (74.2) 
AHS D 2,069 (87.4) 1,072 (87.0) 1,050 (85.2) 
AHS E 2,135 (95.1) 1,312 (94.1) 1,282 (91.9) 
AHS F 2,030 (78.5) 664 (80.9) 648 (78.9) 
Total 10,884 (83.9) 4,654 (85.4) 4,543 (83.3) 
 
Morphology of cancer 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 1,517 (100.0) 473 (100.0) 473 (100.0) 
AHS B 1,623 (99.6) 576 (99.8) 576 (99.8) 
AHS C 2,624 (100.0) 953 (99.9) 953 (99.9) 
AHS D 2,367 (100.0) 1,232 (100.0) 1,232 (100.0) 
AHS E 2,245 (100.0) 1,395 (100.0) 1,395 (100.0) 
AHS F 2,585 (100.0) 821 (100.0) 821 (100.0) 
Total 12,961 (99.9) 5,450 (100.0) 5,450 (100.0) 
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Degree of spread of cancer 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 1,480 (97.6) 447 (94.5) 444 (93.9) 
AHS B 1,573 (96.6) 554 (96.0) 549 (95.1) 
AHS C 2,463 (93.8) 892 (93.5) 876 (91.8) 
AHS D 2,327 (98.3) 1,213 (98.5) 1,200 (97.4) 
AHS E 2,194 (97.7) 1,355 (97.1) 1,337 (95.8) 
AHS F 2,387 (92.3) 753 (91.7) 740 (90.1) 
Total 12,424 (95.8) 5,214 (95.6) 5,146 (94.4) 
 
 
Staging items 
 
Cancer staging - T stage code 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 1,281 (84.4) 377 (79.9) 367 (77.6) 
AHS B 1,318 (80.9) 458 (79.4) 451 (78.2) 
AHS C 1,847 (70.4) 679 (71.2) 655 (68.7) 
AHS D 1,937 (81.8) 1016 (82.5) 993 (80.6) 
AHS E 1,981 (88.2) 1212 (86.9) 1,184 (84.9) 
AHS F 1,951 (75.5) 610 (74.3) 588 (71.6) 
Total 10,315 (79.5) 4352 (79.8) 4,238 (77.7) 
 
Cancer staging - N stage code 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 1,229 (81.0) 366 (77.4) 360 (76.1) 
AHS B 1,312 (80.5) 456 (79.0) 451 (78.2) 
AHS C 1,896 (72.2) 684 (71.7) 661 (69.3) 
AHS D 1,919 (81.1) 1,010 (82.0) 989 (80.3) 
AHS E 1,977 (88.1) 1,191 (85.4) 1,161 (83.2) 
AHS F 1,865 (72.1) 591 (72.0) 572 (69.7) 
Total 10,198 (78.6) 4,298 (78.8) 4,194 (76.9) 
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Cancer staging - M stage code 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 1,097 (72.3) 309 (65.3) 301 (63.6) 
AHS B 1,365 (83.8) 455 (78.9) 448 (77.6) 
AHS C 1,540 (58.7) 537 (56.3) 513 (53.8) 
AHS D 2,060 (87.0) 1,042 (84.6) 1,019 (82.7) 
AHS E 2,196 (97.8) 1,357 (97.3) 1,328 (95.2) 
AHS F 1,782 (68.9) 513 (62.5) 494 (60.2) 
Total 10,040 (77.4) 4,213 (77.3) 4,103 (75.3) 
 
Staging basis 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 1,460 (96.2) 442 (93.4) 433 (91.5) 
AHS B 279 (17.1) 127 (22.0) 111 (19.2) 
AHS C 1,947 (74.2) 691 (72.4) 659 (69.1) 
AHS D 2,274 (96.1) 1,176 (95.5) 1,156 (93.8) 
AHS E 2,214 (98.6) 1,371 (98.3) 1,349 (96.7) 
AHS F 2,504 (96.9) 790 (96.2) 787 (95.9) 
Total 10,678 (82.3) 4,597 (84.3) 4,495 (82.4) 
 
Other staging systems and classifications* 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 974 (64.2) 327 (69.1) 317 (67.0) 
AHS B 190 (11.7) 78 (13.5) 71 (12.3) 
AHS C 17 (0.6) 29 (3.0) 5 (0.5) 
AHS D 1,102 (46.6) 609 (49.4) 593 (48.1) 
AHS E 2,113 (94.1) 1,308 (93.8) 1,260 (90.3) 
AHS F 0 (0.0) 23 (2.8) 0 (0.0) 
Total 4,396 (33.9) 2,374 (43.5) 2,246 (41.2) 
* Optional item  
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Other stage groupings* 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 929 (61.2) 295 (62.4) 284 (60.0) 
AHS B 193 (11.8) 78 (13.5) 71 (12.3) 
AHS C 17 (0.6) 29 (3.0) 5 (0.5) 
AHS D 1,102 (46.6) 609 (49.4) 593 (48.1) 
AHS E 2,107 (93.9) 1,302 (93.3) 1,254 (89.9) 
AHS F 0 (0.0) 22 (2.7) 0 (0.0) 
Total 4,348 (33.5) 2,335 (42.8) 2,207 (40.5) 
* Dependent on above item 
 
TNM stage* 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 552 (36.4) 145 (30.7) 135 (28.5) 
AHS B 0 (0.0) 12 (2.1) 0 (0.0) 
AHS C 2,286 (87.1) 812 (85.1) 779 (81.7) 
AHS D 2,071 (87.5) 1,045 (84.8) 1,019 (82.7) 
AHS E 2,182 (97.2) 1,345 (96.4) 1,307 (93.7) 
AHS F 0 (0.0) 25 (3.0) 0 (0.0) 
Total 7,091 (54.7) 3,384 (62.1) 3,240 (59.4) 
* Not in ClinCR data dictionary and not requested by researchers 
 
TNM edition number* 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 1,507 (99.3) 471 (99.6) 457 (96.6) 
AHS B 0 (0.0) 8 (1.4) 0 (0.0) 
AHS C 2,338 (89.1) 828 (86.8) 789 (82.7) 
AHS D 0 (0.0) 15 (1.2) 0 (0.0) 
AHS E 0 (0.0) 7 (0.5) 0 (0.0) 
AHS F 0 (0.0) 3 (0.4) 0 (0.0) 
Total 3,845 (29.6) 1,332 (24.4) 1,246 (22.9) 
* Not in ClinCR data dictionary and not requested by researchers 
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Treatment items 
 
Treatment modality 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 0 (0.0) 4 (0.8) 0 (0.0) 
AHS B 1,627 (99.9) 577 (100.0) 577 (100.0) 
AHS C 0 (0.0) 32 (3.4) 0 (0.0) 
AHS D 0 (0.0) 29 (2.4) 0 (0.0) 
AHS E 2,135 (95.1) 1,297 (93.0) 1,297 (93.0) 
AHS F 2,585 (100.0) 821 (100.0) 821 (100.0) 
Total 6,347 (48.9) 2,760 (50.6) 2,695 (49.4) 
 
 
Admissions 
 
 n records  
(% of records in ahs) 
n persons  
(% of persons in ahs) 
AHS A 1,135 (74.8) 436 (92.2) 
AHS B 1,278 (78.5) 545 (94.5) 
AHS C 1,949 (74.2) 849 (89.0) 
AHS D 1,443 (61.0) 1,041 (84.5) 
AHS E 1,250 (55.7) 1,203 (86.2) 
AHS F 1,739 (67.3) 746 (90.9) 
Total admissions 8,794 (67.8) 4,820 (88.4) 
 
Date of admission 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 1,129 (99.5) 436 (100.0) 428 (98.2) 
AHS B 1,270 (99.4) 545 (100.0) 538 (98.7) 
AHS C 1,917 (98.4) 848 (99.9) 825 (97.2) 
AHS D 1,412 (97.9) 1,034 (99.3) 1,006 (96.6) 
AHS E 1,190 (95.2) 1,152 (95.8) 1,150 (95.6) 
AHS F 1,730 (99.5) 746 (100.0) 736 (98.7) 
Total 8,648 (98.3) 4,761 (98.8) 4,683 (97.2) 
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Date of discharge 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 1,129 (99.5) 436 (100.0) 428 (98.2) 
AHS B 1,270 (99.4) 545 (100.0) 538 (98.7) 
AHS C 1,879 (96.4) 835 (98.4) 793 (93.4) 
AHS D 1,412 (97.9) 1,034 (99.3) 1,006 (96.6) 
AHS E 1,190 (95.2) 1,152 (95.8) 1,150 (95.6) 
AHS F 1,730 (99.5) 746 (100.0) 736 (98.7) 
Total 8,610 (97.9) 4,748 (98.5) 4,651 (96.5) 
 
Procedure (ICD) version* 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 1,003 (88.4) 422 (96.8) 334 (76.6) 
AHS B 0 (0.0) 4 (0.7) 0 (0.0) 
AHS C 1,836 (94.2) 843 (99.3) 753 (88.7) 
AHS D 0 (0.0) 19 (1.8) 0 (0.0) 
AHS E 0 (0.0) 25 (2.1) 0 (0.0) 
AHS F 1,583 (91.0) 736 (98.7) 618 (82.8) 
Total 4,422 (50.3) 2,049 (42.5) 1,705 (35.4) 
* Not in ClinCR data dictionary and not requested by researchers 
 
Treatment procedure for cancer (1)* 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 1,003 (88.4) 423 (97.0)  337 (77.3) 
AHS B 1,117 (87.4) 541 (99.3) 438 (80.4) 
AHS C 1,836 (94.2) 843 (99.3) 760 (89.5) 
AHS D 1,443 (100.0) 1,041 (100.0) 1,038 (99.7) 
AHS E 1,250 (100.0) 1,203 (100.0) 1,196 (99.4) 
AHS F 1,583 (91.0) 736 (98.7) 638 (85.5) 
Total 8,232 (93.6) 4,787 (99.3) 4,407 (91.4) 
* There are 27 procedure items; this item reflects how many people have at least one procedure code recorded 
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Radiotherapy 
 
 n records  
(% of records in ahs) 
n persons  
(% of persons in ahs) 
AHS A 72 (4.7) 66 (14.0) 
AHS B 44 (2.7) 40 (6.9) 
AHS C 111 (4.2) 100 (10.5) 
AHS D 224 (9.5) 220 (17.9) 
AHS E 166 (7.4) 160 (11.5) 
AHS F 195 (7.5) 176 (21.4) 
Total radiotherapy  812 (6.3) 762 (14.0) 
 
Date of radiotherapy start 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 72 (100.0) 66 (100.0) 66 (100.0) 
AHS B 44 (100.0) 40 (100.0) 40 (100.0) 
AHS C 111 (100.0) 100 (100.0) 99 (99.0) 
AHS D 224 (100.0) 220 (100.0) 220 (100.0) 
AHS E 165 (99.4) 159 (99.4) 159 (99.4) 
AHS F 144 (73.8) 134 (76.1) 127 (72.2) 
Total 760 (93.6) 719 (94.4) 711 (93.3) 
 
Date of radiotherapy end 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 68 (94.4) 64 (97.0) 62 (93.9) 
AHS B 44 (100.0) 40 (100.0) 40 (100.0) 
AHS C 103 (92.3) 93 (93.0) 92 (92.0) 
AHS D 224 (100.0) 220 (100.0) 220 (100.0) 
AHS E 165 (99.4) 159 (99.4) 159 (99.4) 
AHS F 135 (69.3) 129 (73.3) 126 (71.6) 
Total 739 (91.0) 705 (92.5) 699 (91.7) 
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Radiotherapy treatment type 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 71 (98.6) 66 (100.0) 65 (98.5) 
AHS B 42 (95.5) 40 (100.0) 38 (95.0) 
AHS C 80 (72.1) 78 (78.0) 76 (76.0) 
AHS D 224 (100.0) 220 (100.0) 220 (100.0) 
AHS E 166 (100.0) 160 (100.0) 160 (100.0) 
AHS F 179 (91.8) 173 (98.3) 166 (94.3) 
Total 762 (93.8) 737 (96.7) 725 (95.1) 
 
Received radiation dose 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 67 (93.1) 64 (97.0) 61 (92.4) 
AHS B 41 (93.2) 39 (97.5) 37 (92.5) 
AHS C 78 (70.3) 76 (76.0) 73 (73.0) 
AHS D 220 (98.2) 216 (98.2) 216 (98.2) 
AHS E 166 (100.0) 160 (100.0) 160 (100.0) 
AHS F 128 (65.5) 127 (72.2) 121 (68.8) 
Total 700 (86.2) 682 (89.5) 668 (87.7) 
 
Radiation fractions 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 68 (94.4) 64 (97.0) 62 (93.9) 
AHS B 41 (93.2) 39 (97.5) 37 (92.5) 
AHS C 78 (70.3) 76 (76.0) 73 (73.0) 
AHS D 224 (100.0) 220 (100.0) 220 (100.0) 
AHS E 166 (100.0) 160 (100.0) 160 (100.0) 
AHS F 127 (65.1) 126 (71.6) 120 (68.2) 
Total 704 (86.7) 685 (89.9) 672 (88.2) 
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Chemotherapy 
 
 n records  
(% of records in ahs) 
n persons  
(% of persons in ahs) 
AHS A 316 (20.8) 229 (48.4) 
AHS B 313 (19.2) 264 (45.8) 
AHS C 552 (21.0) 300 (31.4) 
AHS D 731 (30.9) 632 (51.3) 
AHS E 719 (32.0) 542 (38.9) 
AHS F 659 (25.5) 502 (61.1) 
Total chemotherapy  3,290 (25.4) 2,469 (45.3) 
 
Date of systemic therapy start 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 316 (100.0) 229 (100.0) 229 (100.0) 
AHS B 312 (99.7) 263 (99.6) 263 (99.6) 
AHS C 552 (100.0) 300 (100.0) 298 (99.3) 
AHS D 731 (100.0) 632 (100.0) 627 (99.2) 
AHS E 712 (99.0) 537 (99.1) 528 (97.4) 
AHS F 479 (72.7) 370 (73.7) 344 (68.5) 
Total 3,102 (94.3) 2,331 (94.4) 2,289 (92.7) 
 
Date of systemic therapy end 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 269 (85.1) 202 (88.2) 185 (80.9) 
AHS B 285 (91.1) 243 (92.0) 236 (89.4) 
AHS C 462 (83.7) 265 (88.3) 229 (76.3) 
AHS D 693 (94.8) 600 (94.9) 587 (92.9) 
AHS E 707 (98.3) 535 (98.7) 523 (96.5) 
AHS F 453 (68.7) 351 (69.9) 323 (64.3) 
Total 2,869 (87.2) 2,196 (88.9) 2,083 (84.4) 
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Systemic therapy protocol name 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 315 (99.7) 228 (99.6) 228 (99.6) 
AHS B 308 (98.4) 261 (98.9) 259 (98.1) 
AHS C 550 (99.6) 298 (99.3) 298 (99.3) 
AHS D 726 (99.3) 628 (99.4) 627 (99.2) 
AHS E 719 (100.0) 542 (100.0) 542 (100.0) 
AHS F 657 (99.7) 500 (99.6) 500 (99.6) 
Total 3,275 (99.5) 2,457 (99.5) 2,454 (99.4) 
 
Number of cycles of systemic therapy 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 248 (78.5) 175 (76.4) 165 (72.1) 
AHS B 299 (95.5) 250 (94.7) 250 (94.7) 
AHS C 479 (86.8) 268 (89.3) 241 (80.3) 
AHS D 729 (99.7) 630 (99.7) 623 (98.6) 
AHS E 693 (96.4) 529 (97.6) 511 (94.3) 
AHS F 473 (71.8) 367 (73.1) 341 (67.9) 
Total 2,921 (88.8) 2,219 (89.9) 2,131 (86.3) 
 
 
Quality of care indicators 
 
Date of referral to cancer specialist 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 195 (12.9) 135 (28.5) 17 (3.6) 
AHS B 744 (45.7) 417 (72.3) 173 (30.0) 
AHS C 302 (11.5) 197 (20.6) 36 (3.8) 
AHS D 1,070 (45.2) 758 (61.5) 346 (28.1) 
AHS E 437 (19.5) 296 (21.2) 41 (2.9) 
AHS F 960 (37.1) 481 (58.6) 96 (11.7) 
Total 3,708 (28.6) 2,284 (41.9) 709 (13.0) 
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Date of consultation with cancer specialist 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 279 (18.4) 182 (38.5) 33 (7.0) 
AHS B 949 (58.3) 483 (83.7) 266 (46.1) 
AHS C 469 (17.9) 270 (28.3) 68 (7.1) 
AHS D 2,209 (93.3) 1,183 (96.0) 1,067 (86.6) 
AHS E 847 (37.7) 553 (39.6) 98 (7.0) 
AHS F 1,148 (44.4) 538 (65.5) 116 (14.1) 
Total 5,901 (45.5) 3,209 (58.9) 1,648 (30.2) 
 
Date of decision to treat 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 61 (4.0) 61 (12.9) 4 (0.8) 
AHS B 41 (2.5) 43 (7.5) 1 (0.2) 
AHS C 81 (3.1) 75 (7.9) 11 (1.2) 
AHS D 220 (9.3) 211 (17.1) 35 (2.8) 
AHS E 309 (13.8) 99 (7.1) 88 (6.3) 
AHS F 132 (5.1) 129 (15.7) 4 (0.5) 
Total 844 (6.5) 618 (11.3) 143 (2.6) 
 
Date of first clinical trials enrolment 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 55 (3.6) 11 (2.3) 11 (2.3) 
AHS B 184 (11.3) 54 (9.4) 53 (9.2) 
AHS C 73 (2.8) 14 (1.5) 12 (1.3) 
AHS D 47 (2.0) 22 (1.8) 17 (1.4) 
AHS E 19 (0.8) 18 (1.3) 2 (0.1) 
AHS F 73 (2.8) 13 (1.6) 12 (1.5) 
Total 451 (3.5) 132 (2.4) 107 (2.0) 
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Date of first multidisciplinary team consultation (MDT) 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 154 (10.2) 32 (6.8) 30 (6.3) 
AHS B 553 (33.9) 166 (28.8) 153 (26.5) 
AHS C 790 (30.1) 228 (23.9) 215 (22.5) 
AHS D 651 (27.5) 282 (22.9) 266 (21.6) 
AHS E 419 (18.7) 232 (16.6) 212 (15.2) 
AHS F 1,140 (44.1) 314 (38.2) 308 (37.5) 
Total 3,707 (28.6) 1,254 (23.0) 1,184 (21.7) 
 
Date of referral to palliative care 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 310 (20.4) 74 (15.6) 68 (14.4) 
AHS B 304 (18.7) 70 (12.1) 66 (11.4) 
AHS C 825 (31.4) 219 (23.0) 205 (21.5) 
AHS D 878 (37.1) 378 (30.7) 363 (29.5) 
AHS E 292 (13.0) 196 (14.1) 171 (12.3) 
AHS F 1,048 (40.5) 220 (26.8) 209 (25.5) 
Total 3,657 (28.2) 1,157 (21.2) 1,082 (19.8) 
 
Performance status at diagnosis 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 444 (29.3) 95 (20.1) 86 (18.2) 
AHS B 544 (33.4) 152 (26.3) 147 (25.5) 
AHS C 450 (17.1) 158 (16.6) 136 (14.3) 
AHS D 801 (33.8) 347 (28.2) 321 (26.1) 
AHS E 952 (42.4) 554 (39.7) 527 (37.8) 
AHS F 315 (12.2) 80 (9.7) 66 (8.0) 
Total 3,506 (27.0) 1,386 (25.4) 1,283 (23.5) 
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Psycho-social referral to 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 713 (47.0) 188 (39.7) 179 (37.8) 
AHS B 1,587 (97.4) 559 (96.9) 552 (95.7) 
AHS C 1,644 (62.6) 507 (53.1) 474 (49.7) 
AHS D 2,358 (99.6) 1,225 (99.4) 1,199 (97.3) 
AHS E 973 (43.3) 597 (42.8) 566 (40.6) 
AHS F 2,382 (92.1) 710 (86.5) 693 (84.4) 
Total 9,657 (74.5) 3,786 (69.4) 3,663 (67.2) 
 
Date of death 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 629 (41.5) 159 (33.6) 156 (33.0) 
AHS B 605 (37.1) 178 (30.8) 174 (30.2) 
AHS C 1,340 (51.0) 372 (39.0) 361 (37.8) 
AHS D 0 (0.0) 24 (1.9) 0 (0.0) 
AHS E 444 (19.8) 295 (21.1) 282 (20.2) 
AHS F 1,156 (44.7) 277 (33.7) 267 (32.5) 
Total 4,174 (32.2) 1,305 (23.9) 1,240 (22.7) 
 
Cause of death 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS A 0 (0.0) 0 (0.0) 0 (0.0) 
AHS B 214 (13.1) 81 (14.0) 76 (13.2) 
AHS C 0 (0.0) 5 (0.5) 0 (0.0) 
AHS D 0 (0.0) 4 (0.3) 0 (0.0) 
AHS E 442 (19.7) 283 (20.3) 268 (19.2) 
AHS F 0 (0.0) 3 (0.4) 0 (0.0) 
Total 656 (5.1) 376 (6.9) 344 (6.3) 
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Appendix 5: Completeness of colorectal dataset extension by AHS 
 
 n records  
(% of records in ahs) 
n persons  
(% of persons in ahs) 
AHS X XXXX (92.7) XXXX (92.4) 
AHS Y XXXX (54.3) XXXX (52.1) 
Total extension  3,413 (26.3) 1,908 (35.0) 
* Blacked out to preserve AHS identity 
 
Presentation 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS X 1,628 (74.2) 793 (68.5) 787 (68.0) 
AHS Y 1,013 (83.1) 591 (78.7) 584 (77.8) 
Total 2,641 (77.4) 1,384 (72.5) 1,371 (71.9) 
 
Method of surgery 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS X 760 (34.6) 395 (34.1) 393 (34.0) 
AHS Y 1,057 (86.7) 632 (84.2) 630 (83.9) 
Total 1,817 (53.2) 1027 (53.8) 1,023 (53.6) 
 
Level of rectal cancer* 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS X 277 (12.6) 130 (11.2) 126 (10.9) 
AHS Y 157 (12.9) 56 (7.5) 55 (7.3) 
Total 434 (12.7) 186 (9.7) 181 (9.5) 
* Number of records (persons) with rectal cancer diagnosis = 1,217 (581), rectosigmoid = 275 (151), total = 1,492 (732) 
 
Residual tumour status 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS X 1,577 (71.9) 834 (72.1) 830 (71.7) 
AHS Y 1,033 (84.7) 618 (82.3) 615 (81.9) 
Total 2,610 (76.5) 1,452 (76.1) 1,445 (75.7) 
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Radial resection margin 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS X 387 (17.6) 176 (15.2) 172 (14.9) 
AHS Y 794 (65.1) 488 (65.0) 484 (64.4) 
Total 1,181 (34.6) 664 (34.8) 656 (34.4) 
 
Lymphovascular invasion 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS X 1,659 (75.6) 885 (76.5) 883 (76.3) 
AHS Y 978 (80.2) 589 (78.4) 586 (78.0) 
Total 2,637 (77.3) 1,474 (77.3) 1,469 (77.0) 
 
Number of lymph nodes examined 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS X 1,770 (80.7) 937 (81.0) 935 (80.8) 
AHS Y 981 (80.5) 597 (79.5) 594 (79.1) 
Total 2,751 (80.6) 1,534 (80.4) 1,529 (80.1) 
 
Number of lymph nodes involved 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS X 1,773 (80.8) 939 (81.2) 935 (80.8) 
AHS Y 987 (81.0) 600 (79.9) 597 (79.5) 
Total 2,760 (80.9) 1,539 (80.7) 1,532 (80.3) 
 
Mismatch repair deficiency (MMRD) 
 Records with data, 
n (% in ahs) 
Persons with any data,  
n (% in ahs) 
Persons with all data,  
n (% in ahs) 
AHS X 1,670 (76.1) 881 (76.1) 879 (76.0) 
AHS Y 1,029 (84.4) 620 (82.6) 617 (82.2) 
Total 2,699 (79.1) 1,501 (78.7) 1,496 (78.4) 
 
 
